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Cobalt(II)-Catalyzed Atom/Group Transfer Reactions: Stereoselective Carbene and 
Nitrene Transfer Reactions 
 
Joshua V. Ruppel 
 
ABSTRACT 
 
Metalloporphyrins have been shown to catalyze many fundamental and 
practically important chemical transformations, some of which represent the first 
demonstrations of these catalytic processes. The most notable examples include an 
assortment of atom/group transfer reactions, such as oxene, nitrene, and carbene 
transfers.  Atom/group transfer reactions allow for the direct conversion of abundant and 
inexpensive alkenes and alkanes into value-added functional molecules.  Previous reports 
from our group have shown that cobalt-porphyrin based carbene and nitrene transfer 
reactions are some of the most selective and practical catalytic systems developed for 
cyclopropanation and aziridination. Backed by a family of D2-symmetric chiral cobalt 
porphyrins our group continues the development of stereoselective carbene and nitrene 
transfer reactions.  
Metal-catalyzed cyclopropanation of olefins with diazo reagents has attracted 
great research interest because of its fundamental and practical importance.  The resulting 
cyclopropyl units are recurrent motifs in biologically important molecules and can serve 
as versatile precursors in organic synthesis.  Supported by a family of D2-symmetric 
 xiv
chiral cobalt porphyrins, we have demonstrated the use of succimidyl diazoacetate as 
carbene source for a highly diastereo- and enantioselective cyclopropanation process.  
The resulting cyclopropyl succinimdyl esters are highly reactive and serve as valuable 
synthons for generating cyclopropylcarboxamides.  We have also developed the first 
cobalt-porphyrin based intramolecular cyclopropanation, which is able to produce the 
resulting bicyclic lactones in high yields and enantioselectivity.  
Nitrene transfer reactions are also an attractive route to produce biologically and 
synthetically important molecules such as amines and aziridines.  Although much 
progress has been made in nitrene transfer reactions utilizing [N-(p-toluenesulfonyl) 
imino]phenyliodinane (PhI=NTs) the nitrene source suffers from several drawbacks.  
Consequently, there has been growing interest in developing catalytic nitrene transfer 
reactions using alternate nitrene sources. To this end, we have utilized arylsulfonyl azides 
as nitrene source to explore their use in the development of a cobalt-porphyrin catalyzed 
enantioselective aziridination system.  The cobalt catalyzed process can proceed under 
mild and neutral conditions in low catalyst loading without the need of other reagents, 
while generating nitrogen gas as the only byproduct.  We have also explored the use of 
arylsulfonyl azides as nitrene source in a cobalt-catalyzed intramolecular C–H amination 
process.   
 1
 
 
 
Chapter 1 
Developments in Cobalt-Catalyzed Carbene and Nitrene Transfer Reactions 
1.1. Introduction 
 Carbene and nitrene transfer reactions have been reviewed extensively and have 
been very active fields of research over the last several decades.1-2  Previous reviews 
focus their attention on the “usual” metal ions capable of mediating carbene and nitrene 
transfer reactions, such as ruthenium3-4, rhodium5-6, and copper7-8.  Effective catalytic 
systems have been developed that achieve high levels of diastereo- and enantioselective 
control with the use of these metals in both carbene and nitrene systems.3-8  In recent 
reviews, cobalt has always taken its place in chapters titled “Other metal catalysts.”  This 
is not due to the inability of cobalt complexes to effectively catalyze atom/group transfer 
reactions or their inability to induce acceptable levels of stereocontrol, but as a 
consequence of the relatively recent insurgence of research dedicated to cobalt catalyzed 
carbene and nitrene transfer reactions.  This review is intended to highlight cobalt’s 
catalytic ability in carbene and nitrene transfer reactions, such as cyclopropanation and 
aziridination.  Special emphasis will be placed on the advances in enantioselective 
catalysis for cyclopropanation and the development of cobalt catalyzed aziridination, as 
well as, the related amination products resulting from those nitrene transfer reactions.  
The current proposed mechanisms of both cobalt-catalyzed cyclopropanation and 
aziridination/amination reactions will also be discussed. 
 2
1.2. Carbene Transfer: Cyclopropanation 
The fundamental and practical importance of cyclopropanes in synthetic organic 
chemistry is well demonstrated.9  Currently, the metal-mediated decomposition of diazo 
reagents and their subsequent reaction with olefins constitute the most direct route to the 
synthesis of these smallest all carbon ring systems.  Prior to the development of catalytic 
systems able to decompose diazo reagents, the Simmons-Smith Reaction was the 
predominate method of generating cyclopropane products.1  At that time, the asymmetric 
synthesis of cyclopropanes required chiral starting materials or starting materials which 
contained chiral auxiliaries to generate products with modest enantiocontrol.1d  Presently, 
the cyclopropanation of olefins with diazo reagents employing chiral metal complexes 
provides the advantage of using achiral reagents and inducing chirality directly from the 
chiral catalysts to generate the optically enriched products.   
The first enantioselective cobalt catalyzed system was first published in 1978.10  
This catalytic system employed a camphor based ligand and required as little as 1 mol % 
of catalyst.  The catalytic system generated cyclopropanes in excellent yields, good 
enantioselectivities (up to 80% optical purity), and was effective with several diazo 
reagents, although it was solely limited to terminal olefins. 
This pioneering work by Nakamura and Otsuka demonstrated that chiral cobalt 
catalysts could effectively achieve high levels of enantiocontrol. This work set the 
standard by which all subsequent cobalt-catalyzed cyclopropanation systems would be 
evaluated against for the cyclopropanation of styrene with α-diazoacetates, such as ethyl 
diazoacetate (EDA) or t-butyl diazoacetate (t-BDA).  The results published in this 
 3
seminal work demonstrated that cobalt catalysts were equally as effective as their Cu, Ru, 
and Rh counterparts.  
1.2.1. Cobalt Salen Catalysts 
 In 1997, Katsuki used the salen ligand as a scaffold for the development of a 
series of Co(II)- and Co(III)-catalysts that could effectively decompose t-butyl 
diazoacetate (t-BDA) and generate cyclopropanes from styrene and other aryl olefins.11  
The most effective of these catalysts could generate cyclopropanes with high trans 
diastereo- and enantioselectivity (Figure 1.1).   
 
Figure 1.1. Co(III)-Salen Catalyzed Cyclopropanation. 
Katsuki followed that work with a second generation of salen catalysts that were 
designed to be cis selective while also allowing for high enantiocontrol.  These Co(II)-
catalysts were sterically more encumbered and employed the use of the additive N-
methylimidazole (NMI) as their 5th coordinate ligand.  The positive additive effect of an 
axial donor ligand increased both the stereoselectivity as well as the yield of the reaction, 
while retaining high asymmetric induction (Figure 1.2).12  
 4
 
Figure 1.2. Co(II)-Salen Catalyzed Cyclopropanation. 
Following the success of Co(II)-salen complex 5, a catalyst was designed which 
incorporated a pendent N-methylimidazole unit to further exploit the use of this axial 
donor ligand effect.  This new generation of catalyst still generated excellent selectivities 
as demonstrated by Co-salen complex 5 (Figure 1.3); however, its catalytic efficiency 
was significantly improved as a result of solvent effects. Toluene was found to give 
superior yields and stereoselectivity in comparison with the previous solvent of choice, 
tetrahydrofuran.13   
NN
O O
Co
Ph + t-BDA
Ph Ph
5 mol % Co(II)-Salen 6
Toluene, RT, 24 h
>99% Yield
cis:trans
99:1
97% ee:-% ee
N
N1a 2
Ph
CO2t-Bu
4
6  
Figure 1.3. Cyclopropanation Utilizing a Co(II)-Salen Catalyst Baring a (NMI) Pendent 
Group. 
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Continued development of Katsuki’s Co-salen catalyzed cyclopropanation system 
further demonstrated the utility of this catalytic process through the intramolecular 
cyclopropanation of allylic diazoacetates.  This catalytic system proved very substrate 
dependent as the allylic substituent greatly affected the reactivity and selectivity of the 
catalytic system.  Despite its lack of substrate scope, the model substrate 7 generated the 
bicyclic product in up to 97% ee (Figure 1.4).14 
NN
O O
Co
R R
5 mol % Co(II)-Salen
THF, RT, 24 h,
1 equiv. NMI
8: R = Me
9: R = H
OPh
O CHN2
O
OH
H
Ph
H
8: 67% yield, 97% ee
9: 75% yield, 95% ee
7a 10a
 
Figure 1.4. Intramolecular Cyclopropanation Utilizing a Co(II)-Salen Catalyst. 
 Katsuki and co-workers were able to develop a cobalt-catalyzed system capable 
of generating the cyclopropane product more efficiently and selectively than the prior 
work of Nakamura and Otsuka.  Their development of a cis selective catalyst remains one 
of the few systems able to obtain the atypical cis-conformation in high diastereomeric 
excess.   
1.2.2. Cobalt Aldiminato Catalysts 
 Previously mentioned in Katsuki’s Co(II)-salen catalytic system, the use of an 
axial donor ligand for cobalt(II)-catalyzed cyclopropanation was first demonstrated on a 
 6
structurally similar catalyst by Yamada in 1999.  A series of donor ligands, which 
included NMI (12a), were screened for their effect on the standard cyclopropanation 
reaction of styrene with t-BDA.  Among those screened, N-methylimidazole (12a) was 
found to be the superior additive for increasing the reaction yield and selectivity of the 
cyclopropanation reactions in reference to those performed without additive (Table 1.1).15 
Table 1.1. [Co(MPAC)] Catalyzed Cyclopropanation with Axial Donor Ligands. 
Ph + t-BDA
Ph
CO2t-Bu
5 mol % 11
10 mol % Additive 12a-d
entrya additive yield (%)b trans : cisc ee (%, trans)d
1 None 62 76:24 74
2 N N
3 N N Ph
4
N
NH
5
N
94
85
27
50
76:24
77:23
73:27
72:28
84
84
80
82
aReaction conditions: 5 mol % of 11, 5.0 mmol of styrene, 1.0 mmol of
t-BDA, and 10 mol % of additive in THF at 25 oC under N2 for 2 hrs.
b Isolated yield. c Determined by GC and/or NMR analysis. d Determined
by chiral HPLC.
Ph Ph
N N
O OO O
Co
11: [Co(MPAC)]
1a 2 4
12a
12b
12c
12d
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Yamada and co-workers continued their work on cobalt-aldiminato catalysis by 
synthesizing and evaluating several catalysts and testing them for efficacy regarding the 
standard cyclopropanation reaction of styrene with t-BDA.  Results indicated that 
typically catalysts that have substituents with increased steric bulk off the ethylene 
diamine bridge and the addition of a bulky pendent ester group could increase both 
product yield and selectivity in comparison to the reaction catalyzed by 12 (Table 1.2, 
entries 1-2).  These catalysts were further investigated through the evaluation of styrene 
derivatives with various electronic and steric environments which to a large extent 
generated the cyclopropanated products in excellent yields and enantioselectivities (Table 
1.2, entries 3-6).16   
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Table 1.2.  Enantioselective Cyclopropanation of Styrene Derivatives with Various 
Co(II)-Aldiminato Catalysts.  
5 mol % Co(II)-Catalyst
10 mol % NMI
Mes Mes
N N
O O
O
O
O
O
Co
Mes Mes
N N
O O
O
O
O
O
Co
Ar
CO2t-Bu
4
Ar + t-BDA
1 2
13 14
entrya olefin yield (%)b trans : cisc ee (%, trans)d
1
3
4
5
6
aReaction conditions: 5 mol % of catalyst, 5.0 mmol of styrene, 1.0 mmol of
t-BDA, and 10 mol % of additive in THF at 25 oC under N2 for 2 hrs.
97 90:10 96
93 90:10 96
85 87:13 96
95 87:13 96
47 47:53 99
Cl
MeO
cat.
99 91:9 96
13
14
13
13
13
13
2
 
1.2.3. Cobalt Porphyrin Catalysts 
 Independently in 2003, the research groups of Cenini and Zhang reported the use 
of cobalt(II) tetraphenylporphyrin ([Co(TPP)]) as an effective catalyst for the 
cyclopropanation of diazoacetates. These initial results provided the first evidence that 
cobalt porphyrins could be used as catalysts for cyclopropanation.17  Although the 
diastereoselectivity was limited in both catalytic systems, both groups were able to 
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demonstrate that changes to the substituents on the porphyrin ring system would effect 
the selectivity.   
 Subsequent investigations by both research groups lead to the use of porphyrins 
with chiral substituents at the meso positions.  These catalysts generated limited 
asymmetric induction, because the chiral subunits had conformations that provided little 
effect on the environment near the metal center, or active site.18  On the other hand, chiral 
substituents attached at the ortho-aryl positions provided the first significant 
enantioselectivities generated by a cobalt-porphyrin catalyzed system (Figure 1.5).17a  
+ EDA
Ph
CO2Et
2 mol % 16
Toluene, 80 oC, 12 h
N
NH N
HN
O
O
O
O
O O
O
O
*R
*R R*
R*
R*
R**R
*R
O O
CH3
O
CH3H3C
R*=
73% yield
trans:cis
36:64
77% ee (cis)
Ph
1a 15 17
16
 
Figure 1.5. Cyclopropanation of Styrene with Chiral Co(II)-Catalyst 16. 
In 2004, Zhang reported the synthesis and evaluation of a new class of D2-
symmetric chiral cobalt(II) porphyrins as cyclopropanation catalysts.  These chiral 
porphyrins were synthesized in a modular approach using palladium catalyzed cross-
coupling reactions which allowed for the production of a diverse collection of ligands 
with varied steric and electronic effects (Figure 1.6).  The versatility of this modular 
chiral cobalt porphyrin catalyst construction is a result of both the selection of chiral 
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substituents at the ortho-aryl postitions and the non-chiral aryl groups that can be used to 
further tune the electronic and steric environment around the metal center (Figure 1.6).  
By changing the chiral amide, each of the 4 possible isomers produced from the 
cyclopropanation of styrene with t-BDA can be selectively accessed (Figure 1.7).19   
N
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R
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O
O
O
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N N
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NH
NH
HN
HN
O
O
O
O
R* *R
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NH
NH
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O
O
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N
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NH
O
O
Co
20f: [Co(P6)]
MeO OMe
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O
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O
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O
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Figure 1.6. Synthesis of D2-Symmetric Chiral Porphyrins and their Cobalt Complexes. 
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N
N N
N
NH
NH
HN
HN
O
O
O
O
R* *R
*RR*
Co
+ t-BDA
CO2t-Bu CO2t-Bu
CO2t-BuCO2t-Bu
cis-(1S,2R): 4c
cis-(1R,2S): 4d
trans-(1R,2R): 4a
trans-(1S,2S): 4b
H
H
H
H
H
H
H
H
Expected
(S)
O
H2N
(R)
O
H2N
(R)
O
H2N
OMe
(S)
O
H2N
OMe
>99:1 dr
95% ee
37:63 dr
96% ee
38:62 dr
96% ee
t-Bu t-Bu
t-Bu t-Bu
1 2
20a,c
(S)-20a
(R)-20a
(R)-20c
(S)-20c
 
Figure 1.7. Stereoselective Cyclopropanation with D2-Symmetric Chiral Co(II)-
Porphyrin Complexes.   
 After its cyclopropanation debut in 2004, the [Co(P1)] catalyst has demonstrated 
efficiency over a remarkable scope of substrates, including styrene derivatives20 as well 
as electron-deficient olefins21 (Table 1.3). For this catalytic system, the greatest positive 
ligand effects were observed with the use of N,N-dimethylaminopyridine (DMAP) as the 
axial donor ligand.  A axial donor ligands were previously demonstrated in both Yamada 
and Katsuki’s cobalt-catalyzed systems to increase the selectivity of the cyclopropanation 
products.12,15   
 Recently, the Zhang group has shown that the use of D2-symmetric chiral cobalt-
porphyrins allow for the employment of other diazo compounds as efficient carbene 
sources, such as diazosulfones (Figure 1.8).  When utilizing diazosulfones as the carbene 
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precursors, cyclopropanation catalyst [Co(P6)] exploits potential hydrogen bonding 
interactions between the assumed cobalt-carbene sulfonyl group and the amide functional 
groups on the porphyrin ligand. This leads to a more rigid and polar chiral environment 
that promotes and stabilizes the carbene intermediate formed from the decomposition of 
the diazosulfones and results in increased selectivity.22   
Table 1.3. Diastereo- and Enantioselective Cyclopropanation of Olefins by [Co(P1)]. 
+ t-BDA
R
CO2t-Bu
1 mol % [Co(P1)]
0.5 equiv DMAP
entrya olefin yield (%)b trans : cisc ee (%, trans)d
1
2
3
4
aReaction conditions: 1 mol % of catalyst, 1.0 equiv of olefin, 1.2 equiv of
t-BDA, and 0.5 equiv of DMAP in toluene at 25 oC under N2 for 20 hrs.
cDetermined by GC. dDetermined by chiral GC or HPLC. eChlorobenzene
was used as solvent.
84 >99:1 95
69 98:2 91
86 98:2 96
74 97:3 84
Cl
MeO
Olefin
F
F
F
F
F
5e
EtO
O
92 99:1 91
6e
H2N
O
77 99:1 97
7e
Et
O
81 99:1 94
8e NC 83 76:24 93
2
4
 
 13
Figure 1.8. Cyclopropanation of Diazosulfones with [Co(P6)]. 
 Zhang and co-workers have expanded the scope of their chiral cobalt(II)-
porphyrin catalyzed cyclopropanation systems further through the use of 
acceptor/acceptor diazo reagents.  Specifically, α-nitrodiazoacetate in the presence of 
[Co(P1)] could generate the atypical Z-substituted cyclopropanes in high yields and 
excellent enantioselectivities (Figure 1.9).23 These highly valuable Z-substituted 
nitrocyclopropanes can be easily converted into α-amino acid derivatives through the 
reduction of the nitro group.   
 
Figure 1.9. Cyclopropanation of α-Nitrodiazoacetate with [Co(P1)]. 
1.2.4. Other Supporting Ligands 
 Several less developed catalysts have been employed for the cyclopropanation of 
olefins by diazo compounds. Among these catalysts, Co(II)phthalocyanine, which is 
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similar to porphyrins in structure, produces the racemic cyclopropane products in 
moderate to high yields.24  No information concerning the stereoselectivity of these 
reactions was reported.  
Inspired by Katsuki’s work with Co-salen catalysts for cyclopropanation, Gao has 
developed a dinuculear cobalt catalyst based upon the salen scaffold (Figure 1.10).25 
Although the dicobalt system is not as effective as the salen ligands developed by 
Katsuki, it does provide a basis for future dinuclear systems employed for carbene 
transfer reactions.   
NN
O O
Co
N N
Co
NN
O O
Co
N N
5 mol % Coupled Salen Complex
DCM, RT
74% yield
trans:cis
69:31
78%ee (trans)
90% yield
trans:cis
72:28
86%ee (trans)
+ EDAPh
1a 15 Ph
CO2Et
17
25 26
 
Figure 1.10. Salen-Based Dicobalt Catalyzed Cyclopropanation. 
 Recently, the research group of Gade developed a pincer type ligand for 
enantioselective catalysis.  The catalytic activity of these new ligands were evaluated in 
the cyclopropanation of styrene with ethyl diazoacetate and produced the corresponding 
cyclopropanes in high yields with excellent diastereo- and high enantioselectivities 
(Figure 1.11).26  
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Figure 1.11. Cyclopropanation with a Co(II)-Pincer Type Ligand. 
 Prior to the Zhang group’s work using D2-symmetric chiral porphyrin ligands, 
they employed the use of the naturally occurring vitamin B12 derivative aquocobalamin.  
Inspired by nature’s use of porphyrin like ring structures in the active sites of many 
enzymes capable of highly selective transformations, vitamin B12 was chosen as a 
potential catalyst for cyclopropanation.  This cobalt(III) catalyst proved to be a cis-
selective catalyst, although it generated only modest enantioselectivities (Figure 1.12).27  
The modest enantioselectivities are not that unexpected as the chiral substituents are on 
the periphery of the corrin ring system and would have a limited inductive effect near the 
metal center, as previously observed with the meso-substituted porphyrin catalysts 
evaluated by the groups of Cenini and Zhang.17a,18 
 16
88% yield
trans:cis
39:61
54% ee: 64% ee
+ EDA
Ph
CO2Et
2 mol % B12 (28)Ph
1a 15
17
N
N N
N
CH3
CONH2
CH3
CH3
CH3
CONH2
CONH2
H2NOC
H
H2NOC
OHN
O
P
H O
O
O
O
OH
N
N
CONH2
Co
R
28 : Vitamin B12
R = HO•HCl
HO
 
Figure 1.12. Cyclopropanation with Vitamin B12 as Catalyst. 
1.2.5. Mechanism 
 The mechanism of cyclopropanation via diazo reagent decomposition is thought 
to proceed via carbene formation followed by the interaction of the olefin to produce the 
cyclopropane product.  Investigations into the nature of the cobalt-carbene intermediate 
were undertaken by Yamada through the use infrared spectroscopy and computational 
studies.  The results of these experiments concluded that the reaction of the diazo 
compound with the cobalt complex 30 results in a surplus of a single electron that is 
delocalized between the carbene carbon and the carbonyl unit resulting in the cobalt(III)-
carbene complex 32 (Figure 1.13).28  This information is combined with the established 
use of a axial donor ligand (L) in cobalt(II)-catalyzed cyclopropanation and the following 
mechanism is proposed (Figure 1.13).   
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Figure 1.13. Proposed Mechanism of Cobalt Catalyzed Cyclopropanation. 
1.3. Nitrene Transfer: Aziridination and Amination 
 In comparison to cobalt-catalyzed cyclopropanation, the analogous aziridination 
is in its infancy in terms of research and development.  The current field of aziridination 
and the related amination process is dominated by Ru4, Rh6, and Cu8 catalytic systems.  
As is the case with diazo reagents for cyclopropanation, the analogous aziridination 
process has been dominated by one class of nitrene source.  The typical nitrene source for 
aziridination has become [N-(p-toluenesulfonyl)imino]phenyliodinane (PhI=NTs) 
reagent.29  In light of its many drawbacks such as limited shelf-life, limited solubility in 
organic solvents, commercial unavailability, and generation of an equivalent of PhI as by 
product, much research has been devoted to the in situ generation of PhI=NTs and its 
related derivatives.4d,6b,8a,30  Aside from these traits, PhI=NTs has become the nitrene 
source of choice for many nitrene transfer reactions.  Cobalt-catalyzed systems have 
successfully provided a platform for the exploration of other nitrene sources that have 
previously been ignored in favor of PhI=NTs, such as bromamine/chloramine-T and 
organic azides as nitrene sources (Figure 1.14).  
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Figure 1.14. Common Nitrene Sources. 
 Much like aziridination, C–H amination employs PhI=NTs and in situ variants as 
the primary nitrene source in many catalytic systems.4a,6a,6c-d,6f  C–H amination can occur 
in competition to the aziridination process when an appropriate activated C–H bond is 
present on an olefin.4c As a result, the cobalt catalyzed amination process has been 
developed in parallel to aziridination including the use of alternate nitrene sources such 
as bromamine/chloramine-T and organic azides.   
 Currently, porphyrin ligands are leading the development of both these cobalt 
catalyzed systems.  This is not entirely surprising as some of the first examples of 
aziridination and amination reactions were explored with metalloporphyrins as 
catalysts.31   
1.3.1. Cobalt Porphyrin Catalyzed Aziridination  
 The first practical and efficient cobalt-catalyzed aziridination system was 
published by Zhang in 2005.  This catalytic system employs the commercially available 
[Co(TDClPP)] as catalyst with bromamine-T as the nitrene source.  Unlike most 
aziridination systems, olefins were used as limiting reagents.  The racemic N-
sulfonylated aziridines were produced from a wide variety of aromatic and aliphatic 
amines in good to high yields (Table 1.4).32   
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Table 1.4. Aziridination of Different Olefins by [Co(TDClPP)]. 
N S
O
O
Na
Br
34a: Bromamine-T
+Olefin
[Co(TDClPP)] 5 mol %
CH3CN, 25 oC, 18 h
NTs
R
entrya olefin yield (%)b
1
2
3
4
5
aReaction conditions: 5 mol % of [Co(TDClPP)], 1.0 equiv of olefin, 2
equiv of bromamine-T in CH3CN 25 oC under N2 for 18 h.
bIsolated yield. c cis:trans = 9:91. d cis:trans = 47:53. ecis:trans = 8:92.
f cis:trans = 58:42.
83
70
product
NTs
NTs
NTs
33
NTs
NTsR
R R
R
NTsn n
R = Me: 94c
R = Ph: 92d
R = Me: 87e
R = Ph: 94f
n = 1: 61
n = 2: 66
n = 3: 79
NTs 56
6
7
8
9
10
11
36
R = Me
R = Ph
R = Me
R = Ph
n = 1
n = 2
n = 3
 
 Zhang and co-workers continued to develop their cobalt-catalyzed aziridination 
through the employment of the commercially available diphenylphosphoryl azide 
(DPPA) as the nitrene source.  Preliminary work catalyzed by [Co(TPP)] demonstrated 
that DPPA could be used to generate the racemic N-phosphorylate aziridines in moderate 
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to good yields (Figure 1.15).33  Unfortunately, DPPA proved be a nitrene source that was 
more limited in scope than bromamine-T.  The cobalt porphyrin catalyzed system which 
utilizes DPPA as the nitrene source is confined to terminal aromatic olefins and requires 
an excess of olefin for efficient catalysis.   
 
Figure 1.15. Aziridination of Styrene Derivatives with DPPA by [Co(TPP)]. 
However, unlike the bromamine-T system, the nitrene source DPPA has been 
developed into one of the first examples of cobalt-catalyzed asymmetric aziridination. 
The D2-symmetric chiral porphyrins, which were also demonstrated as potent catalysts 
for asymmetric cyclopropanation, and generated the aziridine products in moderate yields 
and enantioselectivities (Figure 1.16).34   
 
Figure 1.16. Asymmetric Aziridination with DPPA by [Co(P1)]. 
1.3.2. Cobalt Porphyrin Catalyzed C–H Amination 
 Cenini first demonstrated the use of aryl azides as suitable nitrene sources for 
cobalt-catalyzed amination.  This process generates the amine product exclusively when a 
3o benzylic C–H bond is present.  Secondary and primary C–H bonds generate mixtures 
of amine and imine products through subsequent reactions of the amines with a second 
equivalent of the azide (Figure 1.17).35   
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Figure 1.17. Imine Formation from Catalytic Amination of Benzylic C–H Bonds. 
Table 1.5. [Co(TDClPP)]-Catalyzed Amination with Bromamine-T. 
 
The Zhang group observed amination side products when substrates that had a 
benzylic C–H bonds were employed in the aforementioned bromamine-T aziridination 
system.32  The amine products could be generated in moderate yields and were selectively 
generated at benzylic positions (Table 1.5).36  Although, the amine product was isolated 
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without presence of the imine side-product in other substrates (Table 1.5 entries 1-2 and 
4), the imine product was generated exclusively with substrate 39c (Table 1.5, entry 3). 
1.3.3. Mechanism   
 Very little has been published concerning the mechanism of cobalt-catalyzed 
nitrene transfer reactions.   Previous investigations into the mechanism of copper-
mediated aziridination reactions gave rise to a proposed mechanism involving a 
Cu(I)/Cu(III) catalytic cycle.2d,37  This proposed copper-mediated nitrene transfer 
catalytic cycle combined with the analogous proposed mechanism of cobalt-catalyzed 
cyclopropanation28 can be utilized to propose a mechanistic pathway for cobalt-catalyzed 
nitrene transfer reactions, since the mechanism is likely to follow that of the analogous 
carbene transfer process of cyclopropanation (Figure 1.18).   
The interaction of the cobalt-complex 29 with the nitrene source could generate 
the cobalt-nitrene radical species 44, and the subsequent interaction of an olefin or 
activated C–H bond would then give rise to the aziridination or amination products, 
respectively.  The results published by Zhang in the cobalt-porphyrin catalyzed 
aziridination of olefins with bromamine-T provides evidence for a cobalt-nitrene 
intermediate that undergoes a ring closing step in a non-stereospecific nature.32  
Unfortunately, the cobalt-catalyzed aziridination with DPPA was limited to terminal 
olefins and as a result neither the stereospecificity of the reaction could be determined nor 
could the comparison with the bromamine-T system be made.  
The lack of an asymmetric report using bromamine-T as the nitrene source by the 
Zhang group while DPPA as the nitrene source has provided the first examples of an 
asymmetric cobalt-catalyzed aziridination demonstrates the very unique properties of 
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these two catalytic systems.  This provides evidence that the choice of the nitrene sources 
examined will play a significant roll in the future development and understanding of 
cobalt-catalyzed nitrene transfer reactions.  
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Figure 1.18. Proposed Mechanism of Cobalt-Catalyzed Nitrene Transfer. 
1.4. Conclusions 
 Cobalt-catalyzed cyclopropanation and aziridination have enjoyed a resurgence of 
interest and research in the past 15 years.  The current developments have generated 
some of the most general and selective examples of cyclopropanation catalytic systems 
published, highlighted by the cobalt-catalyzed systems of Katsuki and Zhang.  Although 
the cobalt-catalyzed aziridination and amination systems have not reached the selectivity 
and scope of their carbene counterparts, alternative nitrene sources will allow for the 
continued development and improvement of these catalytic systems.   
 24
 
 
 
Chapter 2 
Cobalt-Catalyzed Enantioselective Intramolecular Cyclopropanation of Allylic 
Diazoacetates 
2.1. Introduction 
 Metal-mediated decomposition of diazo reagents in the presence of olefins has 
proven to be an efficient route to cyclopropanes.1  These carbocycles represent a class of 
compounds that have found numerous fundamental and practical applications in synthesis 
and medicine.9 The intramolecular cyclopropanation of allylic diazo reagents (Figure 2.1) 
provides a means to access a wealth of structures that have proven to be highly useful in 
synthetic chemistry,9a, as in the synthesis of (+)-ambruticin S (48)38 and 
carboxycyclopropyl glycines.39   
 
Figure 2.1.  Intramolecular Cyclopropanation with Allylic Diazoacetates. 
Kirkland’s use of a dirhodium catalyzed intramolecular cyclopropanation of an 
allylic diazoacetate (45)  and subsequent ring opening of the resulting bicyclic lactone 46 
provided the key step in the installation of the cyclopropane ring in the synthesis of (+)-
ambructitin S (48), a potent antifungal (Figure 2.2).38  The syntheses of 
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carboxycyclopropyl glycines employ a similar strategy utilizing allylic 
diazoacetamides.39 
 
Figure 2.2. Intramolecular Cyclopropanation in the synthesis of (+)-Ambruticin S. 
A number of outstanding metal-catalyzed systems have been reported to achieve 
high levels of selectivity for the decomposition of allylic diazo reagents into these 
valuable bicyclic structures (Figure 2.1).3a,14,26,40  The work of Doyle and co-workers with 
chiral dirhodium catalysts have proven to be one of the most selective methods for 
generating excellent enantioselectivities over a range of substrates, but is limited in 
effectiveness when more sterically demanding substrates are used (Figure 2.3).40b-e  The 
research groups of Katsuki and Che-Ming Che have demonstrated the ability of cobalt-
salens and ruthenium-porphyrins to be capable catalysts for the intramolecular 
cyclopropanation process with aryl substituted allylic diazo reagents (Figure 2.3).3a,14  
Continuing research efforts in this field aim at developing a catalytic system that is 
capable of effecting high selectivity over a broad range of substrates.   
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Figure 2.3.  Intramolecular Cyclopropanation with Various Metal-Complexes. 
2.2. Enantioselective Intramolecular Cyclopropanation   
Utilizing a family of cobalt(II) complexes of D2-symmetric chiral porphyrins 
(Figure 2.4)19a, our research group has developed one of the most selective and general 
asymmetric intermolecular cyclopropanation catalytic processes.19-23  The ability of these 
unique chiral cobalt(II) porphyrin complexes to effectively decompose diazo reagents in 
the presence of a broad range olefins to generate high diastereo- and enantioselectivities 
has provided a platform to develop the first chiral cobalt(II) porphyrin catalytic process 
for intramolecular cyclopropanation.   
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Figure 2.4. Structures of D2-Symmetric Chiral Cobalt(II) Porphyrins. 
 This family of D2-symmetric chiral porphyrins (Figure 2.4) was evaluated for its 
ability to catalyze the intramolecular cyclopropanation process with substrate 7a, and 
produced the desired bicyclic product 10a.  Employing [Co(P1)] as catalyst we found the 
intramolecular cyclopropanation process proceeds efficiently with moderate 
enantioselectivity (Table 2.1, entry 1). As seen in previous intermolecular 
cyclopropanation systems, the use of an axial donor ligand, such as DMAP, has a positive 
trans effect and results in an increase in enantioselectivity (Table 2.1, entry 2).19b   
The results demonstrated significant dependence on the bulky nature of the 
ligand.  For example, sterically more encumbered [Co(P2)] catalyzed the reaction with a 
slightly lower yield and enantioselectivity than [Co(P1)].  Catalysts with considerably 
more sterically encumbered ligand designs ([Co(P3-P6)]) were unable to effectively 
generate the bicyclic product (Table 2.1, entries 4-7).   
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Table 2.1. Intramolecular Cyclopropanation by Chiral Cobalt(II) Porphyrins.   
entrya [Co(Por*)]b yield (%)d ee (%)e
[Co(P1)]
[Co(P2)]
[Co(P3)]
[Co(P4)]
[Co(P6)]
3 53
-- --4
75 68
[Co(P5)] 21
--7
5
6
2
1 [Co(P1)] 92 40
-- --
66
-7
--
a Reaction conditions: Performed at 25 oC for 24 h with MeCN as solvent
using 2 mol % of catalyst; [substrate] = 0.2 M. b See Figure 2.4. c 0.5
equiv of additive. d Isolated yield. e Determined by chiral GC.
Ph O
O
N2
O
H
O
[Co(Por*)]
H
Ph
H
H
additivec
--
DMAP
DMAP
DMAP
DMAP
DMAP
DMAP
7a 10a
 
 Upon the discovery of [Co(P1)] as the most capable catalyst, several solvents 
were evaluated for their effect on the selectivity and efficiency of the intramolecular 
cyclopropanation process.  The catalytic system could proceed under a variety of solvent 
conditions including: coordinating solvents (Table 2.2, entries 1-2), a broad range of 
polarities from highly polar ethylacetate to non-polar hexanes (Table 2.2, entries 3-4), as 
well as aromatic and chlorinated solvents (Table 2.2, entries 5-8).  The disparity in 
enantioselectivities was very minimal over this broad range of solvent characteristics; 
however  the efficiency of the reaction diminished when the strongly coordinating solvent 
THF was used as well as the non-polar hexanes which was likely due to poor solubility.  
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Upon achieving these results, DCM was selected as the solvent due to these conditions 
providing the greatest enantioselectivity while retaining a moderate to high yield.   
Table 2.2. Intramolecular Cyclopropanation with [Co(P1)] in Various Solvents.   
a Reaction conditions: Performed at 25 oC for 24 h with 0.5
equiv of DMAP and 2 mol % of catalyst; [substrate] = 0.2 M. b
Isolated yield. c Determined by chiral GC.
Ph O
O
N2
O
H
O
[Co(P1)]
DMAP (0.5 equiv)H
Ph
H
H
entrya solvent yield (%)b ee (%)c
PhCl 75 616
Hexanes 31 654
1 75 68
2 19 67
5 Toluene 66 62
8 DCE 53
3 EtOAc 74 64
58
7 DCM 70 72
MeCN
THF
7a 10a
 
 The importance of DMAP as the axial ligand was investigated by evaluating the 
equivalency requirements of the additive.  It was shown that a decrease or increase in the 
amount of DMAP led to lower yields and little difference in the enantioselectivity (Table 
2.3, entries 1-3).  The decrease in yield is most likely a result of the equilibrium shifting 
from the catalytically active 5-coordinate cobalt complex to either the 6-coordinate 
species that lacks an open coordination site or to the less reactive 4-coordinate species 
without DMAP.  As expected, decreasing the temperature to 0 oC led to a decrease in 
yield and a slight increase in enantioselectivity; similarly, increasing the temperature led 
to the opposite trend (Table 2.3, entries 4-5).  Increasing the reaction time led to an 
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increase in yields as expected, although a negligible drop in enantioselectivity was 
observed (Table 2.3, entry 6).  An increase or decrease in catalyst loading led to the 
corresponding increase or decrease in the yield of the desired product with a negligible 
effect on the enantioselectivity (Table 2.3, entry 7-8). 
Table 2.3. Enantioselective Intramolecular Cyclopropanation with [Co(P1)] Under 
Various Conditions.   
a Reaction conditions: Peformed in the presence of DMAP and [Co(P1)];
[substrate] = 0.2 M. b Isolated yield. c Determined by chiral GC.
Ph O
O
N2
O
H
O
[Co(P1)]
DCMH
Ph
H
H
entrya yield (%)b ee (%)c
1 70 72
DMAP
(equiv) time (h) temp (
oC)
0.5 24 25
[Co(P1)]
(mol %)
2%
2 57 680.25 24 252%
3 50 690.75 24 252%
4 37 760.5 24 02%
5 76 640.5 24 402%
6 82 670.5 48 252%
7 75 680.5 24 255%
8 54 690.5 24 251%
7a 10a
 
 The use of [Co(P1)] with a substoichiometric amount of DMAP as the axial donor 
ligand was evaluated with several trans-allylic substrates to probe the scope and 
effectiveness of the catalytic intramolecular cyclopropanation process.  A series of aryl 
substituted allylic diazoacetates with varying electronic and steric properties were 
evaluated with [Co(P1)] for their ability to form the bicyclic products.  The p-methyl and 
o-methyl substitutions dramatically increased both the yields and enantioselectivity, with 
84% and 78% ee, respectfully (Table 2.4, entry 2-3).  The sterically demanding p-tertiary 
 31
butyl group led to a noticeable decrease in enantioselectivity while generating a moderate 
yield (Table 2.4, entry 4).  Both electron-donating and electron-withdrawing groups were  
well tolerated demonstrating the lack of sensitivity to electronic effects (Table 2.4, entries 
5-6).  The heteroaromatic 2-substituted furan substrate was also well tolerated, although a 
decrease in enantioselectivity was observed (Table 2.4, entry 7).  Disubstituted allylic 
diazoacetates proved to be excellent substrates for the intramolecular cyclopropanation 
process with [Co(P1)] generating excellent yields and enantioselectivities at both room 
temperature and 40 oC (Table 2.4, entry 8-9).   
Interestingly, the use of a cis-substituted allylic diazoacetate 7j in the presence of 
[Co(P1)] and with DMAP as the axial donor ligand generated the product in decreased 
yield and enantioselectivity, but with the same conformation as the trans-substituted 
substrate 7a (Table 2.4, entries 1 and 10).  This result indicates the intramolecular 
cyclopropanation system proceeds through a non-stereospecific step-wise pathway.   
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Table 2.4. [Co(P1)]-Catalyzed Enantioselective Intramolecular Cyclopropanation of 
Allylic Diazoacetates.   
entrya yield (%)b ee (%)cRt
9 90 (86)e35 (62)e
70 (76)e 72 (64)e
p-MeOC6H4 7088
94 78o-CH3C6H4
p-tBuC6H4 2676
77 632-furan
p-BrC6H4 8384
1
5
p-CH3C6H4 84952
35 20H10
Rc
H
H
C6H5
CH3 CH3
C6H5 H
H
H
H
H
86 (>99)e 79 (79)eC6H58 CH3
7
6
4
3
a Reaction conditions: Performed at 25 oC for 24 h using 2 mol % of [Co(P1)]
with 0.5 equiv of DMAP in DCM; [substrate] = 0.2 M. b Isolated yield. c
Determined by chiral GC. d Sign of optical rotation. e Reactions performed at
40 oC.
Rt O
O
N2
O
Rc
O
[Co(P1)]
Rc
Rt
H
H
[ ]d
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
7a-j 10a-i
Diazo Product
7a
7b
7c
7d
7e
7f
7g
7h
7i
7j
10a
10b
10c
10d
10e
10f
10g
10h
10i
10a
 
2.3. Mechanism of Co(II)-Porphyrin Catalyzed Intramolecular Cyclopropanation 
The observation of a non-stereospecific product is indicative of a radical based 
mechanism.  Although the radical nature of cobalt(II) carbene intermediates have been 
established by Yamada and co-workers,28 further investigation of the catalytic system 
shows this mechanism is highly dependant upon the use of an axial donor ligand, in this 
case DMAP.  When the cis-substituted substrate 7j is decomposed in the presence of 
[Co(P1)] without DMAP, a mixture of diasteromers are isolated, representing the 
stereospefic α,α,α-10j and non-sterospecific α,α,β-10a products (Figure 2.5).  The 
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mixture of products observed for both the reactions, with and without DMAP, leads to 
interesting mechanistic implications.   
Figure 2.5. Stereospecificity of [Co(P1)]-Catalyzed Intramolecular Cyclopropanation. 
 
 The interaction of the allylic diazoacetate with the cobalt-complex liberates 
nitrogen gas and generates the cobalt-carbene species.  Presumably, when an axial donor 
ligand, such as DMAP, is used, this cobalt carbene species forms the 6-coordinate species 
53. The resulting carbene-cobalt-DMAP complex is stable enough that the subsequent 
interaction with the olefin allows for the formation of the benzylic radical intermediate 
54, and through a slow ring closing step is able to produce α,α,β-10a.  Conversely, the 
absence of the axial donor ligand, DMAP, produces a more reactive intermediate, the 
benzylic radical 52, and results in a fast ring closing step and generates both the 
stereospecific α,α,α-10j product and α,α,β-10a confirmation (Figure 2.5).   
This phenomenon has also been observed with the Ru-porphyrin intramolecular 
cyclopropanation system of Che-Ming Che and coworkers, who observed a mixture of 
the α,α,α-10j and α,α,β-10a diastereomers when 7j was employed in their system.3a  Che-
Ming Che also attributes this observation to a probable step-wise mechanism.  It is worth 
noting that this observation was not made in the Rh2-catalytic intramolecular 
cyclopropanation system of Doyle when the same 7j substrate was utilized.40b  
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Figure 2.6. Proposed Mechanism for the Non-stereospecific [Co(P1)]-Catalyzed 
Intramolecular Cyclopropanation. 
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2.4. Conclusions 
 The chiral cobalt(II)-porphyrin complex [Co(P1)] was shown to be an effective 
catalyst for the intramolecular cyclopropanation of allylic diazoacetates.  Further studies 
are needed to develop a catalytic system that will enjoy excellent selectivity over a 
broader range of substrates.  Continued investigations into the use of axial donor ligands 
and their effect on the selectivity and mechanism of this reaction are warranted.   
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Chapter 3 
Asymmetric Cobalt-Catalyzed Cyclopropanation with Succinimidyl Diazoacetate:  
General Synthesis of Optically Active Cyclopropyl Carboxamides 
3.1. Introduction 
The importance of cyclopropanes in numerous fundamental and practical 
applications has stimulated an interest in the stereoselective synthesis of these 
carbocycles.9 Metal catalyzed asymmetric cyclopropanation of olefins with diazo 
reagents constitutes the most direct and general approach for the construction of 
cyclopropane derivatives.1  A number of outstanding chiral catalysts have been used to 
achieve high diastereo- and enantioselectivity for several classes of cyclopropanation 
reactions, most of which have employed diazoacetates.3,5,7 Ongoing endeavors in 
asymmetric cyclopropanation are aimed at further expanding the substrate scope to 
include different types of olefins with various kinds of carbene sources, including 
different classes of diazo reagents. 
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Figure 3.1. Synthetic Routes to Chiral Cyclopropanecarboxamides. 
In contrast to the large body of excellent results achieved with diazoacetates,3,5,7 
diazoacetamides have not been successfully employed for asymmetric intermolecular 
cyclopropanation (Figure 3.1).  Except for the Rh2-based intramolecular reactions 
reported by Doyle and co-coworker40b,d the majority of the published reports using 
diazoacetamides are non-asymmetric systems.41 The absence of effective intermolecular 
asymmetric cyclopropanations with diazoacetamides may be attributed to two major 
factors: (i) the inherent low reactivity of the resulting metal-carbene intermediate due to 
reduced electrophilicity and increased steric hindrance, and (ii) complications resulting 
from competitive intramolecular C–H insertion (Figure 3.2).42   
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Figure 3.2. Intramolecular C–H Insertion with Diazoacetamides.  
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Inspired by their important biomedical applications (Figure 3.3),43 a post-
derivatization approach was applied to the synthesis of chiral cyclopropyl carboxamides 
57 in enantioenriched forms through the reaction of preformed cyclopropyl chiral 
building blocks 56 with various amines (Figure 3.1). Utilizing a cobalt-catalyzed 
asymmetric cyclopropanation process with succinimidyl diazoacetate (55: 
N2CHCO2Su),44 in the presence of olefins generates the cyclopropane products in high 
yields and excellent diastereo- and enantioselectivities.  As a result of the high reactivity 
of hydroxysuccinimide esters, the cyclopropyl products could serve as convenient 
synthons for the general preparation of chiral amides through reactions with a range of 
different amines, and without loss of pre-established enantiomeric purity (Figure 3.1). 
N
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OEt
Br
N
O
S
OTBDMS
O
O
CO2H
N O
N
O
Ph
S
H
H
61
HIV-1
Reverse Transcriptase Inhibitor
62
Antibacterial
-Lactamse Inhibitor
63
Memory Impairment
Prolyl Endopeptidase Inhibitor  
Figure 3.3. Examples of Important Biologically Active Chiral Cyclopropyl 
Carboxamides. 
3.2. Diastereo- and Enantioselective Cyclopropanation with Succinimidyl 
Diazoacetate   
The well-defined cobalt(II) complexes of D2- symmetric chiral porphyrins 
([Co(Por*)])19a have emerged as a class of effective catalysts for asymmetric 
cyclopropanation reactions with both electron-sufficient20 and electron-deficient21 olefins 
using diazoacetates, diazosulfones22, and α-nitro-diazoacetates.23 Among this family of 
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([Co(Por*)]), a group of six derivatives [Co(P1–P6)] (Figures 3.4), possess diverse 
electronic, steric, and chiral environments, were evaluated as potential catalysts for 
asymmetric cyclopropanation of styrene with the sterically bulky N2CHCO2Su (Table 
3.1). 
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Figure 3.4. Structures of D2-Symmetric Chiral Cobalt(II) Porphyrins. 
 As a practical attribute of [Co(Por*)]-catalyzed cyclopropanation, these reactions 
were carried in a one-pot fashion with styrene as the limiting reagent, and without the 
occurrence of common diazo dimerization side reaction. Upon examination of the results 
(Table 3.1), it was evident that the steric bulkiness of the carbene source played a role in 
the differences observed between these catalysts. For example, no reactions were 
observed with the more sterically encumbered catalysts [Co(P4)], [Co(P5)], and [Co(P6)] 
(Table 3.1, entries 4–6). Furthermore, the yields of the desired cyclopropane 56a when 
sterically unhindered catalysts [Co(P1)], [Co(P2)], and [Co(P3)] were employed 
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correlated well with the ligand environment (Table 3.1, entries 1–3). For these reactions, 
outstanding diastereoselectivities were achieved, with trans-56a produced as the sole 
diastereomer. While the best enantioselectivity was attained by [Co(P2)], the use of 
[Co(P1)] afforded the best yield in addition to high enantioselectivity. Reduction of the 
N2CHCO2Su from 1.5 to 1.2 equivalents gave similarly high diastereo- and 
enantioselectivity for the [Co(P1)]-catalyzed reaction, but resulted in decreased yields 
(Table 1, entries 1 and 7). As demonstrated previously, a positive trans effect on 
enantioselectivity was observed upon addition of DMAP (Table 1, entries 7–9). Although 
selectivity was not affected by lowering the catalyst loading or reducing the reaction 
time, a decrease in the overall product yield was observed (Table 1, entries 10 and 11). 
Finally, toluene seemed to be the solvent of choice as the use of other solvents, such as 
chlorobenzene, led to lower yields and decreased enantioselectivities (Table 1, entry 12). 
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Table 3.1. Asymmetric Cyclopropanation of Styrene with Succinimidyl Diazoacetate by 
D2-Symmetric Chiral Cobalt(II) Porphyrins.   
+
N2
H
O
O
N
O
O
O
O N
O
O
[Co(Por*)]
entrya [Co(Por*)]b yield (%)c ee (%)e
[Co(P2)]
[Co(P3)]
[Co(P4)]
[Co(P5)]
[Co(P1)]
3 10
0 --4
70 96
[Co(P6)] 0
747f
5
6
2
1 [Co(P1)] 86 92
0 --
63
--
91
a Reaction conditions: Performed at 25 oC for 48 h with toluene
as solvent using 5 mol% of catalyst with 1.0 equiv of styrene
and 1.5 equiv of N2CHCO2Su in the presence of 0.5 equiv of
DMAP; [styrene] = 0.25 M. b See Figure 3.4. c Isolated yield.
d Determined by NMR or HPLC. e Trans isomer ee was
determined by chiral HPLC. f 1.2 equiv of N2CHCO2Su. g 24 h.
h 2 mol %. i Performed in chlorobenzene.
additive
DMAP
DMAP
DMAP
DMAP
DMAP
DMAP
DMAP
trans:cisd
8f
9f
10f,g
11f,h
12f,i
[Co(P1)]
[Co(P1)]
[Co(P1)]
[Co(P1)]
[Co(P1)]
NMI
--
DMAP
DMAP
DMAP
85
86
66
64
67
>99:01
>99:01
>99:01
--
--
--
>99:01
>99:01
>99:01
>99:01
>99:01
>99:01
88
88
91
91
87
1a
55 56a
 
 Under the optimized reaction conditions, different olefin substrates were 
subjected to catalytic cyclopropanation using N2CHCO2Su. As demonstrated in these 
select examples (Table 3.2), both electron-sufficient and electron-deficient olefins could 
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be successfully cyclopropanated by [Co(P1)]. For example, asymmetric cyclopropanation 
of styrene derivatives bearing various substituents, including alkyl and halide groups as 
well as electron donating and withdrawing groups, could be catalyzed by [Co(P1)] to 
form the corresponding cyclopropanes 56a-f in good yields with outstanding 
diastereoselectivities and excellent enantioselectivities (Table 3.2, entries 1, 3, 5, 7, 9 and 
11). Further improvement in enantioselectivity was achieved uniformly for all these 
substrates when the relatively bulkier [Co(P2)] was employed as the catalyst, albeit in 
lower yields (Table 3.2, entries 2, 4, 6, 8, 10, and 12). In addition, the Co-based catalytic 
process showed significant functional group tolerance as demonstrated with the reactions 
of acetoxy- and nitrosubstituted styrenes to form 56g-h (Table 3.2, entries 13 and 14).  
Due to the steric bulkiness of N2CHCO2Su, the catalytic system was less efficient for 
large aromatic olefins as exemplified by the [Co(P1)]-catalyzed cyclopropanation 
reaction of 2-vinylnaphthalene, offering 56i in low yield (Table 3.2, entry 15). In addition 
to aromatic olefins, the [Co(P1)]/N2CHCO2Su-based system could also selectively 
cyclopropanate the challenging electron-deficient olefins, such as α,β-unsaturated esters, 
amides, and ketones (Table 3.2, entries 16–18). It is worth noting that the cyclopropanes 
prepared from these olefins (56j-l) are highly electrophilic in nature and have proven to 
be valuable synthetic intermediates.45 
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Table 3.2. [Co(P1)]-Catalyzed Diastereo- and Enantioselective Cyclopropanation of 
Different Alkenes with Succinimidyl Diazoacetate.   
entrya yield (%)b ee (%)d
70 962f
1 86 92
a Reaction conditions: Performed at 25 oC for 48 h with toluene as solvent using 5 mol %
[Co(P1)] with 1.0 equiv of styrene and 1.5 equiv of N2CHCO2Suc in the presence of 0.5
equiv of DMAP; [styrene] = 0.25 M. b Isolated yield. c Determined by NMR or HPLC. d Trans
isomer ee was determined by chiral HPLC. e Sign of optical rotation. f [Co(P2)] as catalyst. g
[1R, 2R] absolute configuration by X-ray crystal structural analysis and optical rotation.
trans:cisc
>99:01
>99:01
[ ]e
(-)
(-)
4f
3
71 96
90 95>99:01
98:02
(-)g
(-)g
81 98
80 97>99:01
>99:01
(-)
(-)6f
5
75 97
71 95>99:01
99:01
(-)
(-)8f
7
10f
9
12f
11
48 92
66 90>99:01
>99:01
(-)
(-)
30 94
77 90>99:01
>99:01
(-)
(-)
13
14
15
16
17
18
71 91>99:01 (-)
50 92>99:01 (-)
33 9199:01 (-)
57 89>99:01 (-)
52 96>99:01 (-)
55 91>99:01 (-)
CO2Su
cyclopropane
CO2Su
CO2Su
t-Bu CO2Su
MeO CO2Su
Cl CO2Su
F3C CO2Su
AcO
CO2SuO2N
CO2Su
O
CO2Su
O
CO2Su
O
N
Et
Me
Me
O
CO2SuMe
56a
56b
56c
56d
56e
56f
56g
56h
56i
56j
56k
56l
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3.3. Post-Derivitization Approach for the Synthesis of Optically Active Cyclopropyl 
Carboxamides 
 With the established availability of enantioenriched succinimidyl cyclopropyl 
carboxylate derivatives through the [Co(P1)]-catalyzed asymmetric cyclopropanation 
with N2CHCO2Su, the potential application of these derivatives as chiral building blocks 
for the synthesis of cyclopropyl carboxamides  (Figure 3.1) was subsequently explored. 
Using [1R, 2R]-56a as a representative synthon, a range of different amines were 
examined for the post-derivatization synthetic approach (Table 3.3). Both aliphatic and 
aromatic amines reacted with 56a smoothly, affording the desired cyclopropyl 
carboxamides with retention of configuration (Table 3.3, 57a and 57b). The 
transformation of 56a into the corresponding primary amide using ammonia also 
occurred in high yield and without loss of diastereo- and enantioselectivity (Table 3.3, 
57c).  Cyclic amines such as pyrrolidine and morpholine could also be effectively 
converted to the corresponding amides in high yields with complete preservation of the 
stereochemistry (Table 3.3, 57d and 57e). Owing to the mild and neutral reaction 
conditions, the post-derivatization approach was able to tolerate a number of different 
functional groups as exemplified by the reactions with chiral α-amino acids such as 
methyl (S)-phenylalaninate as well as chiral α-amino alcohols such as (S)-phenylalaninol 
and (R)-valinol (Table 3.3, 57f, 57g, and 57h). The resulting multi-functional cyclopropyl 
amides, bearing three stereogenic centers, could be isolated as single diastereomers in 
good to excellent yields. 
 To further demonstrate the utility of this approach, [1R, 2R]-56a was allowed to 
react with the unprotected tripeptide [S]- H2N-Gly-Gly-Ala-COOH and D-glucosamine at 
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room temperature in a mixture of water and THF (Table 3.3). The corresponding 
cyclopropyl carboxamides were isolated as single diastereomers in 60% and 47% yield, 
respectfully, without affecting the hydroxylic and carboxylic functionalities. 
Table 3.3. Synthesis of Chiral Cyclopropanecarboxamides.   
O
O N
O
O
a Reaction conditions: Performed at 25 oC in THF open to air for 30 min; Isolated yields; de
determined by NMR or HPLC; ee determined by chiral HPLC. b 24 h. c NH3/Dioxane (1.0 M). d
Isolated as single diastereomer. e Performed in THF:H2O:Et3N (1:1:0.05). f 1 h. g Isolated a
mixture of anomers : (2:1).
NH
R1
R2
O
N R
1
R225 oC
56a[-1R,2R] 92%ee>99% de 57-[1R,2R]
a
O
N C6H13
H
O
N
H
57a-[1R,2R]
92% yield
88%ee
>99% de
OMe
57b-[1R,2R]b
62% yield
89%ee
>99% de
O
N H
H
57c-[1R,2R]c
93% yield
92%ee
>99% de
O
N
57d-[1R,2R]
93% yield
92%ee
>99% de
O
N
57e-[1R,2R]
93% yield
92%ee
>99% de
O
N
H
57f-[1R,2R,3S]d,e,f
66% yield
O
O
OMe
O
N
H
OH O
N
H
OH
O
N
H
O
N
H
O
O
O CH3
OH
O
57g-[1R,2R,3S] d
93% yield
57h-[1R,2R,3R] d
54% yield
57j-[1R,2R,3S]b,d,e
60% yield
57i-[1R,2R,3R]e,f,g
47% yield
HO
OH
HO
OH
1
2 2
1
3 3
3
3
3
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3.4. Conclusions 
 We have shown that the succinimidyl cyclopropyl carboxylate derivatives can be 
generated in excellent diastereo- and enantioselectivities through a broad range of 
terminal olefins utilizing [Co(P1)] and [Co(P2)] as catalysts.  We have also shown that 
the use of succinimidyl cyclopropyl carboxylate derivatives can be used as a convenient 
synthons to produce the corresponding cyclopropyl carboxamides under mild conditions 
with excellent functional group tolerance without loss of the pre-established enantiomeric 
purity.   
The analogous transformation utilizing cyclopropyl esters generated from EDA or 
t-BDA would require heating and possibly long reaction times to generate the 
cyclopropyl carboxamide derivatives.  This could lead to loss of the pre-established 
enantiomeric purity through epimerization.  Many amines could require the 
transformation of the ester to an acid chloride so that a sufficiently electrophilic carbon 
would be available for the reaction, limiting the efficiency of the reaction and introducing 
harsh reaction conditions.   
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Chapter 4 
Cobalt-Catalyzed Olefin Aziridination with Arylsulfonyl Azides 
4.1. Introduction 
 Metal-catalyzed olefin aziridination is a fundamentally and practically important 
chemical process that is receiving an increasing amount of research attention.2 The 
resulting aziridines are key elements in many biologically and pharmaceutically 
interesting compounds and serve as valuable synthons for the preparation of 
functionalized amines.46   
The greatest progress in catalytic aziridination has been made utilizing PhI=NTs 
and related iminoiodane derivatives.4,6,8  Since the introduction of PhI=NTs as a nitrene 
source, considerable progress has been made in metal-catalyzed olefin aziridination with 
notable developments with the use of in situ generation of PhI=NTs and variants.4d,6b,8a,30  
Despite these advances, the continued search for alternative nitrene sources is warranted 
as the use of PhI=NTs has been met with several difficulties. Besides its short shelf life 
and poor solubility in common solvents, the catalytic process generates a stoichiometric 
amount of PhI as byproduct from the decomposition of PhI=NTs.   
In view of their similarity to diazo reagents for carbene transfer processes, azides 
may have the potential to serve as a general class of nitrene precursors in metal-mediated 
nitrene transfer reactions, including aziridination (Figure 4.1).  In addition to their wide 
availability and ease of synthesis, azide-based nitrene transfer reactions would generate 
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nitrogen gas as the only byproduct.  Despite these attributes, only a few catalytic systems 
have been developed, both non-asymmetric and asymmetric, that can effectively catalyze 
the aziridination process.2e,4a-b,37,47,48  
 
Figure 4.1. Cobalt-Catalyzed Olefin Aziridination with Arylsulfonyl Azides. 
4.2. Hydrogen Bonding Guided Catalyst Design   
We have reported a catalytic cobalt-porphyrin based system for the aziridination 
of olefins with azides, specifically diphenylphosporyl azide (DPPA).33  It was shown that 
[Co(TPP)] (Figure 4.2) could catalyze olefin aziridination with the commercially 
available DPPA as the nitrene source, leading to the formation of N-phosphorylated 
aziridines.  Recently, this work was expanded to employ chiral cobalt porphyrins as 
catalysts which allowed for modest enantioselectivities.34   
 
Figure 4.2. Structures of Cobalt(II) Porphyrin Catalysts. 
In an attempt to expand the scope of the catalytic process to other azides, it was 
found that [Co(TPP)] was a poor catalyst choice for olefin aziridination with arylsulfonyl 
azides as the nitrene sources.  The desired aziridines 65a-c were obtained in 11-24% 
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yields from the reaction of styrene with common azides 64a-c (Table 4.1).  Similarly, 
Co(TDClPP)] (Figure 4.2), which was shown to be an effective catalyst for azidination30 
and amination34 with bromamine-T, produced the desired product in trace amounts for 
each azide screened (Table 4.1). 
Table 4.1. Aziridination of Styrene with Arylsulfonyl Azides with Different Cobalt(II) 
Porphyrins.   
65aa
65ba
65ca
+ S
O
O
Ar N3
N
SO2Ar[Co(Por)]
N
S
O
O
N
S
O
O
OMe
N
S
O
O
N
H
O
18%
24%
<10%
<10%
<10%
<10%
94%
88%
98%
entrya aziridine [Co(TPP)] [Co(TDClPP)] [Co(P7)]
1
2
3
a Reaction conditions: Performed at 40 oC for 18 h with C6H5Cl as solvent using
2 mol % of catalyst in the presence of 4 Å MS; styrene:azide = 5:1; [azide] = 0.2 M.
64a-c
65aa-ca
 
 As part of our efforts to develop a cobalt-porprhyin based catalytic system, we 
developed a new cobalt-porphryin catalyst, [Co(P7)] (Figure 4.2), to exploit potential 
hydrogen bonding interactions between the assumed cobalt-nitrene sulfonyl group and 
the amide functional groups on the porphyrin ligand.  [Co(P7)] was shown to be a highly 
active catalyst for the aziridination of aromatic olefins with various arylsulfonyl azides, 
forming the corresponding aziridines in excellent yields under mild conditions.  Under 
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the same conditions used as the aforementioned reactions by [Co(TPP)] and 
[Co(TDClPP)], we found that employment of [Co(P7)] resulted in a dramatic 
improvement of the catalytic aziridination (Table 4.1).  The desired aziridines were 
obtained in 88-98% yields, which supports the hydrogen bonding catalyst design. 
In addition to azides 64a-c that contain p-methyl, p-methoxy, and p-acetamide 
groups (Table 4.2, entries 1-3), [Co(P7)] could effectively activate a wide range of 
arylsulfonyl azides (Table 4.2).  The use of arylsulfonyl azides having p-cyano, p-nitro, 
and o-nitro substituents afforded the corresponding aziridines in excellent yields as well 
(Table 4.2, entries 4-6).  The [Co(P7)]-catalytic system could also accommodate the 
much bulkier naphthalene-1-sulfonyl azide to produce the resulting aziridine product in 
97% yield (Table 4.2, entry 7).   
 It was found that the [Co(P7)] system could be applied to various combinations of 
olefins and azides.  Using azide 64e as the nitrene source, various styrene derivatives as 
well as 2-vinylnapththalene could be aziridinated in high to excellent yields (Table 4.3).  
While most of the reactions were carried out with 5 equivalents of olefin, the catalytic 
process could also be operated with olefin as limiting reagent albeit with a slight decrease 
in yield (Table 4.3, entries 1-2, 5-6, 8).  To further demonstrate the utility of [Co(P7)], 
azide 64c was also employed as the nitrene source for the aziridination of various 
aromatic olefins and produced the aziridines in excellent yields (Table 4.4). 
 
 
 
 
 50
Table 4.2. [Co(P7)]-Catalyzed Aziridination of Styrene with Arylsulfonyl Azides. 
+ S
O
O
Ar N3
N
SO2Ar
N
S
O
O
N
S
O
O
OMe
N
S
O
O
N
H
O
94
88
98
entrya aziridine yield (%)b
1
2
3
azide
SO2N3
SO2N3MeO
SO2N3HN
O
SO2N3NC
SO2N3O2N
SO2N3
NO2
SO2N3
N
S
O
O
CN
N
S
O
O
NO2
N
S
O
O
N
S
O
O
O2N
4
5
6
7
88
97
96
97
a Reaction Conditions: Performed in C6H5Cl for 18 h at 40 oC in the
presence of 4 Å MS using 2 mol % of [Co(P7)]; styrene:azide = 5:1; [azide] =
0.2 M. b Isolated yields.
[Co(P7)]
64a-g
65aa-ga
65aa
65ba
65ca
65da
65ea
65fa
65ga
64a
64b
64c
64d
64e
64f
64g
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Table 4.3. Aziridination of Aromatic Olefins by [Co(P7)]. 
entrya aziridine yield (%)b
1
2
azide
N
S
O
O
NO2
a Reaction Conditions: Performed in C6H5Cl for 18 h at 40 oC in the
presence of 4 Å MS using 2 mol % of [Co(P7)]; olefin:azide = 5:1; [azide] =
0.2 M. b Isolated yields. c olefin:azide = 1:1.2.
olefin
64e
64e
97
(90)c
N
S
O
O
NO2
89
(83)c
3 64e
N
S
O
O
NO2
89
4 64e
N
S
O
O
NO2
88
5 64e
N
S
O
O
NO2
98
(97)ct-Bu t-Bu
6 64e
N
S
O
O
NO2
94
(83)cCl Cl
7 64e
N
S
O
O
NO2
96
Br Br
8 64e
N
S
O
O
NO2
95
(90)cF F
9 64e
N
S
O
O
NO2
96
F3C F3C
10 64e
N
S
O
O
NO2
75
65ea
65eb
65ec
65ed
65ee
65ef
65eg
65eh
65ei
65ej
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Table 4.4. Aziridination of Aromatic Olefins with 64c by [Co(P7)]. 
entrya aziridine yield (%)b
1
2
azide
N
S
O
O
NHC(O)Me
a Reaction Conditions: Performed in C6H5Cl for 18 h at 60 oC in the
presence of 4 Å MS using 2 mol % of [Co(P7)]; olefin:azide = 5:1; [azide] =
0.2 M. b Isolated yields.
olefin
64c
64c
98
N
S
O
O
NHC(O)Me
83
3 64c
N
S
O
O
NHC(O)Me
84
t-Bu t-Bu
4 64c
N
S
O
O
NHC(O)Me
93
Cl Cl
65ca
65cb
65ce
65cf
 
4.3. Enantioselective Aziridination of Arylsulfonyl Azides 
 The hydrogen bonded catalyst design, which led to the development of [Co(P7)] 
as an effective catalyst for olefin aziridination with arylsulfonyl azides, provides a basis 
for the employment of D2-symmetric chiral porphyrins, which have shown to be very 
effective catalysts for cyclopropanation,19-23 for the development of a cobalt-based 
enantioselective aziridination system.  The D2-symmetric porphyrins (Figure 4.3) 
developed by our group employ the use of a quadruple amidation reaction to install the 
chiral amides to the ortho-phenyl positions of the core tetraphenylporphyrin ring system 
in much the same way that [Co(P7)] was synthesized.19a  Not only does this reaction 
install the chiral groups in an orientation that allows for significant asymmetric induction, 
as shown by our results in cyclopropanation,19-23 but it also forms the same basic ligand 
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structure as [Co(P7)], which allows for potential hydrogen bonding between the 
porphyrin ligand’s amide functional groups and the sulfonyl groups of the proposed 
metal-nitrene complex.  The convenient modular design of the chiral cobalt-porphyrin 
allows us to develop this asymmetric cobalt-catalyzed olefin aziridination reaction.  
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
Co
20a: [Co(P1)]
N
N
N
N
HN
HN
O
O
NH
NH
O
O
Co
20f: [Co(P6)]
MeO OMe
OMeMeO
O O
OO
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
Co
20b: [Co(P2)]
OMeMeO
OMeMeO
H
H
H
H
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
Co
20e: [Co(P5)]
O O
O
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
OMe MeO
MeOOMe
Co
20c: [Co(P3)]
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
OMe MeO
MeOOMe
Co
20d: [Co(P4)]
OMeMeO
OMeMeO
O
Figure 4.3. Structures of D2-Symmetric Chiral Cobalt(II) Porphyrins. 
 In the initial screening of select D2-symmetric chiral cobalt(II) porphyrins, 
[Co(P1)] and [Co(P4)] (Figure 4.3), demonstrated that the aziridination of styrene with 
azide 64e could be generated in moderate yields and enantioselectivities (Table 4.5, 
entries 1-2).  Catalyst [Co(P4)] was chosen to screen a series of additives for increases in 
catalytic efficiency and selectivity.  A slight positive additive effect on selectivity was 
previously demonstrated in the asymmetric aziridination of olefins with DPPA by 
[Co(P1)].32  It was shown that strongly donating axial ligands inhibited the reaction from 
proceeding, including the use of a substoichiometric amount of THF as additive (Table 
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4.5, entries 1-6 and 8).  The use of phthalimide and the common solvents, ethanol and 
methanol, led to decreases in yield with no significant change in asymmetric induction 
(Table 4.5, entries 7 and 9-10).  
Table 4.5. Additive Effects of Asymmetric Aziridination. 
entrya [Co(Por*)]b yield (%)c ee (%)d
[Co(P4)]
[Co(P4)]
[Co(P4)]
[Co(P4)]
3 --
-- --4
44 61
[Co(P4)] --
5
6
2
1 [Co(P1)] 94 13
-- --
--
--
a Reaction conditons: Performed at 25 oC for 18 h in C6H5Cl using 2
mol % of catalyst in the presence of 4 Å MS and 0.2 equiv of additive;
olefin:azide = 5:1; [azide] = 0.2 M. b See Figure 4.3. c Isolated yield. d
Determined by chiral HPLC.
+
[Co(Por*)]
Additive
(0.2 equiv)
SO2N3
O2N
N
S
O
O
NO2
additive
--
--
DMAP
PPh3
NMI
NBI
[Co(P4)]
[Co(P4)]
[Co(P4)]
[Co(P4)]
8 --
33 609
10 65
10
7
41 61
--
Phthalimide
THF
EtOH
MeOH
64e
64ea
 
 Increasing the catalyst loading to 5 mol % and allowing for longer reaction times 
resulted in both increased yields and enantioselectivies with the use of [Co(P1-6)] as 
catalysts (Table 4.6, entries 1-6).  Of the cobalt-catalysts screened, [Co(P6)] was shown 
to be the catalyst most capable of achieving respectable levels of enantioslectivity.  In 
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order to probe for conditions that would favor an increase in the enantioselectivity of the 
products when utilizing [Co(P6)] as catalyst, the reaction was performed with decreased 
catalyst loading, temperature, and time.  Unfortunately, none of these changes in reaction 
conditions provided the positive effect on enantioselectivity that was desired; instead 
these conditions negatively effected the yield of the reaction (Table 4.6, entries 7-9).  
Further attempts to optimize the enantioselectivity led to the screening of various non-
coordinating solvents; however, none of the solvents screened showed a significant 
improvement in enantioselectivity and many yields were substantially diminished (Table 
4.6 entries 10-15).  The use of the non-halogenated solvent ethyl acetate, deactivated the 
catalyst through potential axial coordination and resulted in the failure to produce the 
desired aziridine (Table 4.6, entry 16).    
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Table 4.6. Asymmetric Aziridination by D2-Symmetric Chiral Cobalt(II) Porphyrins.   
entrya [Co(Por*)]b yield (%)c ee (%)d
[Co(P2)]
[Co(P3)]
[Co(P4)]
[Co(P5)]
3 80
82 694
82 30
[Co(P6)] 68
5
6
2
1 [Co(P1)] 94 22
75 51
21
88
a Reaction conditions: Performed at 25 oC for 48 h in C6H5Cl using
5 mol % of catalyst in the presence of 4 Å MS; olefin:azide = 5:1;
[azide] = 0.2 M. b See Figure 4.3. c Isolated yield. d Determined by
chiral HPLC. e 2 mol % [Co(P6)]. f Performed at 0 oC. g 18 h.
+
[Co(Por*)]
PhCl; 4 Å MS
SO2N3
O2N
N
S
O
O
NO2
solvent
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
[Co(P6)]
[Co(P6)]
[Co(P6)]
[Co(P6)]
12 65
67 8913
41 81
[Co(P6)] 22
14
15
11
10 [Co(P6)] 21 88
21 82
86
85
C6H5CH3
C6H5CF3
1,2-C6H4Cl2
1,3-C6H4Cl2
DCM
1,2-DCE
[Co(P6)] --16 --EtOAc
[Co(P6)] 527e 86C6H5Cl
[Co(P6)] --8f --C6H5Cl
[Co(P6)] 409g 85C6H5Cl
64e
65ea
 
 The cobalt-catalyzed system was evaluated against a number of arylsulfonyl 
azides containing various functional groups, such as p-methyl, p-methoxy, p-cyano, p-
nitro, and o-nitro groups, which led to large variations in yields although they all 
generated similar enantioselectivities (Table 4.7).  Presumably, the similarity of the 
enantioselectivities is due to the activation and stabilization effects resulting from the 
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hydrogen bonding of the porphyrin ligand with the assumed cobalt-nitrene intermediate.  
These interactions allow for comparable asymmetric inductions to be observed as a 
reflection of their structurally similar proposed intermediates.   
Table 4.7. [Co(P6)]-Catalyzed Asymmetric Aziridination of Styrene. 
+ S
O
O
Ar N3
N
SO2Ar[Co(P6)]
PhCl; 4 Å MS
N
S
O
O
N
S
O
O
OMe
5
9
entrya aziridine yield (%)b
1
2
azide
SO2N3
SO2N3MeO
SO2N3NC
SO2N3O2N
SO2N3
NO2
N
S
O
O
CN
N
S
O
O
NO2
N
S
O
O
O2N
3
4
5e
44
68
<30
a Reaction Conditions: Performed in C6H5Cl for 48 h at 25 oC in the presence of 4 Å MS
using 5 mol % of [Co(P6)]; styrene:azide = 5:1; [azide] = 0.2 M. b Isolated yields. c
Determined by chiral HPLC. d Sign of optical rotation. e Contaminated by azide starting
material.
86
88
ee (%)c
87
88
70
64a-b,d-f
65aa-ba,da-fa
64a
64b
64d
64e
64f
65aa
65ba
65da
65ea
65fa
[ ]d
(-)
(-)
(-)
(-)
(-)
 
 Utilizing azide 64e as the nitrene source, it was demonstrated that various styrene 
derivatives as well as 2-vinylnapththalene could afford the aziridines in moderate yields 
and good enantioselectivities with the use of [Co(P6)] as catalyst (Table 4.8).   
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Table 4.8. Asymmetric Aziridination of Aromatic Olefins by [Co(P7)]. 
entrya aziridine yield (%)b
1
2
azide
N
S
O
O
NO2
a Reaction Conditions: Performed in C6H5Cl for 48 h at 25 oC in the presence of 4 Å MS
using 5 mol % of [Co(P6)]; olefin:azide = 5:1; [azide] = 0.2 M. b Isolated yields. c
Determined by chiral HPLC. d Sign of optical rotation.
Olefin
64e
64e
68
N
S
O
O
NO2
59
3 64e
N
S
O
O
NO2
47
4 64e
N
S
O
O
NO2
47
5 64e
N
S
O
O
NO2
62
t-Bu t-Bu
6 64e
N
S
O
O
NO2
63
Cl Cl
7 64e
N
S
O
O
NO2
75
Br Br
8 64e
N
S
O
O
NO2
74
F F
9 64e
N
S
O
O
NO2
65
F3C F3C
10 64e
N
S
O
O
NO2
57
ee (%)c
88
81
80
85
78
82
86
88
76
ND
65ea
65eb
65ec
65ed
65ee
65ef
65eg
65eh
65ei
65ej
[ ]d
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
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4.3. Conclusions 
 We have developed a cobalt(II)-porphyrin based catalyst design which exploits 
the potential hydrogen bonding interactions of the porphyrin ligand with the proposed 
cobalt-nitrene intermediates generated from the use of arylsulfonyl azides as nitrene 
precusors.  This discovery led to the implementation of a family of D2-symmetric chiral 
cobalt porphyrins for the assessment of their value as asymmetric aziridination catalysts.  
This investigation has revealed a very effective catalyst, [Co(P6)], that could be 
employed for a variety of arylsulfonyl azides with aromatic olefins.  Although currently 
limited in olefin substrate scope, the development of other arylsulfonyl azides as nitrene 
sources will potentially further expand the substrate scope to include multi-substituted 
olefins and aliphatic olefins.   
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Chapter 5 
Cobalt-Catalyzed Intramolecular C–H Amination with Arylsulfonyl Azides 
5.1. Introduction 
Metal-mediated C–H amination reactions represent an important chemical process 
that can transform compounds with ubiquitous C–H bonds into value added nitrogen 
containing molecules, such as amines.2,49  Significant research has been devoted to the 
use of PhI=NTs and related iminoiodane derivatives as nitrene sources for the catalytic 
amination of C–H bonds.8c,50  Great efforts have been made to overcome several 
limitations associated with the use of hypervalent iodine reagents, such as PhI=NTs, 
which include their instability and the generation of a full equivalent of ArI as byproduct.  
While the approach of in situ iminoiodane generation in the presence of a terminal 
oxidant has met with success recently, 4d,6b,8a,30 alternate nitrene sources, chloramine-
T,8c,51 bromamine-T,32,36,52 and tosyloxycarbamates53 have been actively pursued to 
improve catalytic nitrene transfer reactions, including aziridination and C–H amination.   
Azides represent a broad class of compounds that have the potential to be 
considered as an ideal nitrene source for metal-mediated nitrene transfer reactions.2c,47  In 
addition to their ease of synthesis and availability, azide-based nitrene transfers generates 
nitrogen gas as the only byproduct.  Despite these attributes, only a few catalytic systems 
have been developed that can effectively catalyze the decomposition of azides for nitrene 
transfer reactions, specifically C–H amination.  Notable examples include Co(Por)-based 
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amination with aryl azides,4a,35 a Ru(Salen)-based aziridination, where amination is noted 
as a side product,4c and a dirhodium system capable of intramolecular amination of vinyl 
azides.6e  
As an extension of our previous work with Co(TPP)-based amination of benzylic 
C–H bonds with bromamine-T as the nitrene source and inspired by the current 
developments with the use of arylsulfonyl azides as nitrene sources in catalytic 
aziridination, we have developed a Co-catalyzed intramolecular C–H amination process 
with azides as nitrene sources.  Commercially available Co(TPP) was shown to be an 
effective catalytst for the intramolecular nitrene insertion of C–H bonds utilizing a broad 
range of arylsulfonyl azides and leading to the syntheses of the corresponding 
benzosultam derivatives (Figure 5.1), which have been found in various important 
applications.54  The Co-mediated process proceeds efficiently under mild conditions 
without the need for other additives, while generating nitrogen gas as the only byproduct.   
R6
R5
R4
R3
S
R2
R1
H
O O
N3
R6
R5
R4
R3
S
R2 R
1
O O
NH
[M(Por)]
69 70  
Figure 5.1. Catalytic Intramolecular C–H Amination of Arylsulfonyl Azides. 
5.2. Intramolecular C–H Amination with Arylsulfonyl Azides   
Using the commercially available 2,4,6-triisopropylbenzenesulfonyl azide (69a) 
as a model substrate, we first surveyed the potential catalytic activity of various 
metalloporphryins (Figure 5.2) toward intramolecular C–H amination (Table 5.1).  The 
reactions were carried out with 2 mol % of metalloporphyrin at 80 oC overnight in 
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chlorobenzene, which was previously identified as the solvent of choice for aziridination 
with arylsulfonyl azides and diphenylphosphoryl azides.33,34  It was evident that Co(II) 
was by far the most active metal ion for the intramolecular C–H amination using 
tetraphenylporphryin (TPP) as the supporting ligand, forming the desired benzosultam 
70a in 96% yield (Table 5.1, entry 5).  Complexes of other first row transition metal ions 
supported by TPP produced no or only trace amounts of 70a (Table 5.1, entries 1-3, 6-8),  
with the exception of Fe(TPP)Cl that generated 11% yield of the desired product (Table 
5.1, entry 4).  Although not as effective as Co(II), Ru(TPP)(CO) could catalyze the 
amination reaction and generated the benzosultam 70a in 67% yield (Table 5.1, entry 9).   
Table 5.1. C–H Amination of 69a Catalyzed by Metalloporphyrins.   
S
H
O O
N3 S
O O
NH
[M(TPP)]
Entrya [M(Por)]b Yield (%)c
1
2
3
4
5
6
7
8
9
[V(TPP)Cl]
[Cr(TPP)Cl]
[Mn(TPP)Cl]
[Fe(TPP)Cl]
[Co(TPP)]
[Ni(TPP)]
[Cu(TPP)]
[Zn(TPP)]
[Ru(TPP)CO]
0
0
<5
11
96
0
0
0
67
aReaction conditions: Performed in C6H5Cl at 80 oC
for 18 h and 2 mol% of catalyst in the presence of 5 Å
molecular sieves; [substrate] = 0.20 M.b See Figure
5.2. c Isolated yields.
69a 70a
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Figure 5.2. Structures of Metalloporphyrin Catalysts. 
 With the superiority of the cobalt system established, several common porphyrins 
with differing electronic and steric properties were applied to probe the ligand effect 
(Figure 5.2).  While both Co(OEP) and Co(TMeOPP) could effectively catalyze the 
reaction (Table 5.2, entries 1-2), an increase in ligand steric hindrance and/or electron 
deficiency resulted in poor catalytic activity (Table 5.2, entries 3-5).  The Co(TPP)-
catalyzed reaction could also proceed well at lower temperatures, including room 
temperature (Table 5.2, entries 7-8), and in different solvents (Table 5.2, entries 9-10).  
As expected, a decrease in catalyst loading from 2 mol % to 0.5 mol % moderately 
decreased the yield and required longer reaction times although there was no dramatic 
adverse effect on the catalytic process (Table 5.2, entries 11-12).  Control experiments 
showed that no reaction was observed in the absence of catalyst (Table 5.2, entry 13).  
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Table 5.2. C–H Amination of 69a Catalyzed by Cobalt(II) Porphyrins. 
S
H
O O
N3 S
O O
NH
[Co(Por)]
entrya [M(Por)]b Yield (%)d
1
2
3
4
5
7
8
9
10
[Co(OEP)]
[Co(TMeOPP)]
[Co(TMP)]
[Co(TPFPP)]
[Co(TDClPP)]
[Co(TPP)]
[Co(TPP)]
[Co(TPP)]
[Co(TPP)]
86
93
30
8
5
95
91
91
85
aReaction conditions: Performed under N2 for 18 h in the presence of 5 Å
molecular sieves; [substrate] = 0.20 M.b See Figure 5.2. c Catalyst loading. d
Isolated yields. e Carried out for 42 h.
mol (%)c solvent temp (oC)
11
12
13
[Co(TPP)]
[Co(TPP)]
--
88
92e
00.0
0.5
0.5
2.0
2.0
2.0
2.0
2.0
2.0
2.0
2.0
2.0
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5Cl
C6H5CH3
CH2Cl2
6 [Co(TPP)] 962.0 C6H5Cl
C6H5Cl
80
80
80
80
80
80
80
80
80
40
23
23
23
69a 70a
 
The Co(TPP) catalytic system was found to be suitable for a broad range of 
arylsulfonyl azides (Table 5.3).  Probing the reactivity of each arylsulfonyl azide 
substrate, the catalytic reactions were evaluated at three separate temperatures: 80 oC, 40 
oC, and room temperature.  In addition to intramolecular nitrene insertion into tertiary C–
H bonds (Table 5.3, entries 1-2), secondary (Table 5.3, entries 3-4), and even primary 
(Table 5.3, entries 5-7) C–H bonds having various aromatic substitution patterns could be 
effectively aminated.  These substrates led to the selective formation of the corresponding 
five-membered heterocycles.  Although they all could be intramolecularly inserted in 
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excellent yields at 80 oC, the reactivity pattern of the C–H bonds could be observed at 
lower temperatures and followed in the order of 3o > 2o > 1o (Table 5.3, entries 1-7).  It is 
interesting to note that increases in aromatic ring substitution led to higher-yielding 
formations of the aminated products (Table 5.3, entries 5-7) suggesting a positive 
buttressing effect of meta- and para- groups on the nitrene insertion into ortho C–H 
bonds.  Arysulfonyl azides containing electron-withdrawing functional groups, such as 
bromo and nitro substituents could also be successfully catalyzed (Table 5.3, entries 8-9). 
Table 5.3. [Co(TPP)]-Catalyzed Intramolecular C–H Amination.  
aReaction conditions: Performed under N2 in C6H5Cl for 18 h with 2 mol% of [Co(TPP)] in the
presence of 5 Å molecular sieves; [substrate] = 0.20 M.b Isolated yields. e Carried out for 42 h.
NH
S
OO
80
40
Rt
96
95
91
NH
S
OO
80
40
Rt
94
82
72
NH
S
OO
80
40
Rt
90
54
19
NH
S
OO
80
40
Rt
91
57
40
NH
S
OO
Br
80
40
Rt
93
77
46
S
NH
O OO2N 80
40
Rt
99
85
69
NH
S
OO 80
40
Rt
96
32
18
NH
S
OO
80
40
Rt
91
58
37
NH
S
OO
80
40
Rt
95
79
47
S
O O
NH
80
40
Rt
87
33
23
sultam temp (oC) sultam temp (oC)entrya entryayield(%)b yield (%)b
1
2
3
4
5
6
7
8
9
10
70a
70b
70c
70d
70e
70f
70g
70h
70i
70j
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The aforementioned C–H bond reactivity order of 3o > 2o > 1o in combination 
with the higher reactivity of the activated benzylic C–H bonds, resulted in the exclusive 
formation of five-membered ring structures in all the above cases where 1o and 3o or 1o 
and 2o C–H bonds coexist in the substrate (Table 5.3, entries 1-4 and 8-9).  As in the 
other cases mentioned above (Table 5.3, entries 1-4 and 8-9), the exclusive high-yielding 
formation of five-membered spiroheterocyclic product was observed from a substrate 
contained both 2o and 3o C–H bonds (Table 5.3, entry 10).   
However, when both five- and six-membered ring formations were observed an 
azide substrate containing two different 2o C–H bonds, such as benzylic and non-benzylic 
types was employed.  For example, Co(TPP)-catalyzed intramolecular C–H amination of 
azide 69k with an n-butyl group led to the production of six-membered 70kb as well as 
the five-membered 70ka (Table 5.4, entries 1-3).  The ratio of 70ka to 70kb was 
determined to be 72:28, 68:32, and 67:33 at 80 oC, 40 oC, and room temperature, 
respectively.  The increase in the ratio of 70ka to 70kb at elevated temperatures suggests 
the greater thermodynamic stability of the five-membered ring structure.  Similarly, when 
69l with an n-propyl group was used, both the five-membered 70la and six-membered 
70lb were formed (Table 5.4, entries 4-6); however, the ratio of five- to six-membered 
ring products was significantly lower than those of azide 69k.  Our preliminary results 
indicated that the ratio of five- and six-membered ring formation could be influenced 
sterically and electronically through the use of different porphyrin ligands.  While a 
similar ratio of 70la to 70lb was obtained for Co(TMP)- or Co(TMeOPP)-catalyzed 
reactions (Table 5.4, entries 7-8), the ratio was significantly increased to 73:27 when 
Co(OEP) was used as catalyst (Table 5.4, entry 9).   
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Table 5.4. Five- and Six-Membered Ring Formation via Intramolecular C–H Amination 
Catalyzed by Cobalt Porphyrins. 
S
C3H7
H
O O
N3 S
O O
NH[Co(Por)]
entrya [Co(Por)]b yield (%)d
1
2
3
4
5
7
8
9
[Co(TPP)]
[Co(TPP)]
[Co(TPP)]
[Co(TPP)]
[Co(TPP)]
[Co(TMP)]
[Co(TMeOPP)]
[Co(OEP)]
91
41
25
94
56
77
97
92
aReaction conditions: Performed in C6H5Cl for 18 h with 2 mol% of [Co(Por)] in
the presence of 5 Å molecular sieves; [substrate] = 0.20 M.b See Figure 5.2. c
Ratio of 5- and 6-membered ring products determined by NMR. d Combined
isolated yields.
temp (oC)
6 [Co(TPP)] 33
80
40
23
80
40
23
80
80
80
C4H11 C4H11 S
O O
C4H11 NH
C2H5C3H7
S
C2H5
H
O O
N3 S
O O
NH[Co(Por)]
C3H7 C3H7 S
O O
C3H7 NH
CH3C2H5
+
+
azide sultam
70ka + 70kb
70ka + 70kb
70ka + 70kb
70la + 70lb
70la + 70lb
70la + 70lb
70la + 70lb
70la + 70lb
70la + 70lb
distributionc
72 + 28
68 + 32
67 + 33
56 + 44
56 + 44
54 + 46
55 + 45
73 + 27
59 + 41
69k
69k
69k
69l
69l
69l
69l
69l
69l
69k
69l
70ka 70kb
70la 70lb
 
5.3. Conclusion 
 We have developed the first Co-based catalytic system for intramolecular C–H 
amination with azides.  We have demonstrated that the commercially available Co(TPP) 
is an effective and general catalyst for intramolecular C–H amination with arylsulfonyl 
azides.  This catalytic process generates the potentially valuable benzosultam derivatives 
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in excellent yields.  In addition to 1o, 2o, and 3o benzylic C–H bonds, non-benzylic C–H 
bonds can also be aminated.   Continuing efforts are underway to identify suitable 
catalysts with high regioselectivity toward either five- or six-membered ring formation.  
In addition, current research also includes the use of chiral porphyrins as ligands to 
support a cobalt-based asymmetric C–H amination catalytic system.   
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Chapter 6 
Experimental Procedures and Compound Characterization 
6.1. General Considerations 
 All catalytic reactions were performed under nitrogen in oven-dried glassware 
following standard Schlenk techniques unless otherwise specifically noted.  Toluene was 
distilled under nitrogen from sodium benzophenone ketyl prior to use. Chlorobenzene 
and dichloromethane were dried over calcium hydride under nitrogen and freshly distilled 
before use.  4 Å molecular sieves were dried in a vacuum oven prior to use. Chemicals 
were purchased from commercial sources and used without further purification unless 
specifically noted.  Thin layer chromatography was performed on Merck TLC plates 
(silica gel 60 F254). Flash column chromatography was performed with Merck silica gel 
(60 Å, 230-400 mesh, 32-63 μm).  1H NMR and 13C NMR were recorded on a Varian 
Inova400 (400 MHz) or a Varian Inova500 (500 MHz) with chemical shifts reported 
relative to residual solvent. Infrared spectra were measured with a Nicolet Avatar 320 
spectrometer with a Smart Miracle accessory. HRMS data was obtained on an Agilent 
1100 LC/MS/TOF mass spectrometer.  HPLC measurements were carried out on a 
Shimadzu Prominence LC-20AT HPLC system with a SPD-N20A diode array detector.  
Enantiomeric excess was measured using either a Chiralcel OD-H or Chiralcel AD-H 
chiral HPLC column.  Optical rotation was measured on a Rudolf Autopol IV 
polarimeter.   
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6.2. Supporting Information for Chapter 2 
 An oven dried Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, was charged with diazoacetate (0.2 mmol, if solid), catalyst, and DMAP.  
The Schlenk tube was then evacuated and back filled with nitrogen.  The Teflon screw 
cap was replaced with a rubber septum and 0.5 ml portion of solvent was added followed 
by diazo (0.2 mmol, if liquid), and the remaining solvent (total 1 mL).  The Schlenk tube 
was then purged with nitrogen for 1 minute and the rubber septum was replaced with a 
Teflon screw cap.  The Schlenk tube was then placed in an oil bath for the desired time 
and temperature.  Following completion of the reaction, the reaction mixture was purified 
by flash chromatography.  The fractions containing product were collected and 
concentrated by rotary evaporation to afford the compound. In most cases, the product 
was visualized on TLC using the cerium ammonium molybdate (CAM) stain.   
O
H
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[1R-(lα;5α,6β]-6-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one (10a) was obtained using the 
general procedure in 70% yield (24.3 mg). [α]20D = 61 (c = 2.05, CHCl3, 66%ee). 
Configuration drawn is based upon optical rotation and comparison with literature.40b  1H 
NMR (400 MHz, CDC13): δ 7.31-7.21 (m, 3H), 7.05-7.04 (m, 2H), 4.45 (dd, J = 4.8, 9.6 
Hz, 1H), 4.39 (d, J = 9.6 Hz, 1H), 2.53-2.49 (m, 1H), 2.33-2.30 (m, 2H).  13C NMR (100 
MHz, CDC13): δ 174.9, 137.1, 128.7, 127.1, 125.9, 69.69, 29.34, 27.36, 26.12. IR (neat, 
cm-1): 2923 (C-H), 2852 (C-H), 1740 (C=O).  HRMS (ESI): Calcd. for C11H11O2 
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([M+H]+) m/z 175.0759, Found 175.0765.  GC/MS: Chiraldex G-TA (initial temperature: 
150 oC; isothermal for 34 mins; temperature increased 5.0 oC per min to a final 
temperature of 180 oC):  72%ee; 19.7 min (major) 21.8 min (minor).   
 
[1R-(lα;5α,6β]-6-para Methylphenyl-3-oxabicyclo[3.1.0]hexan-2-one (10b) was 
obtained using the general procedure in 95% yield (35.9 mg).  [α]20D = 66 (c = 3.5, 
CHCl3).  Configuration drawn by analogy based upon optical rotation with known 
compounds in literature.40b  1H NMR (400 MHz, CDC13): δ 7.11 (d, J = 8.4 Hz, 2H), 6.96 
(d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.40 (d, J = 9.6 Hz, 1H), 2.51-2.48 (m, 
1H), 2.32 (s, 3H), 2.30-2.29 (m, 2H).  13C NMR (100 MHz, CDC13): δ 175.1, 136.8, 
134.1, 129.3, 125.8, 69.69, 29.12, 27.24, 25.94, 20.93. IR (neat, cm-1): 2979 (C-H), 2848 
(C-H), 1766 (C=O).  HRMS (ESI): Calcd. for C12H13O2 ([M+H]+) m/z 189.0915, Found 
189.0919.  GC/MS: Chiraldex G-TA (initial temperature: 150 oC; isothermal for 60 mins; 
temperature increased 4.0 oC per min to a final temperature of 180 oC; isothermal for 30 
mins): 84%ee; 30.6 min (major) 33.2 min (minor).   
O
H
O
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[1R-(lα;5α,6β]-6-ortho Methylphenyl-3-oxabicyclo[3.1.0]hexan-2-one (10c) was 
obtained using the general procedure in 94% yield (35.2 mg).  [α]20D = 24 (c = 1.16, 
CHCl3).  Configuration drawn by analogy based upon optical rotation with known 
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compounds in literature.40b  1H NMR (400 MHz, CDC13): δ 7.19-7.13 (m, 3H), 6.95 (d, J 
= 6.8 Hz, 1H), 4.48 (dd, J = 4.8, 9.6 Hz, 1H), 4.43 (d, J = 9.6 Hz, 1H), 2.58-2.54 (m, 1H), 
2.43 (s, 3H), 2.35-2.33 (m, 1H), 2.31-2.29 (m, 1H).  13C NMR (100 MHz, CDC13): δ 
175.2, 137.5, 134.7, 130.2, 127.3, 126.1, 125.4, 69.68, 27.62, 25.99, 24.59, 19.55. IR 
(neat, cm-1): 2979 (C-H), 2904 (C-H), 1766 (C=O).  HRMS (ESI): Calcd. for C12H13O2 
([M+H]+) m/z 189.0915, Found 189.0905.  GC/MS: Chiraldex G-TA (initial temperature: 
150 oC; isothermal for 60 mins; temperature increased 4.0 oC per min to a final 
temperature of 180 oC; isothermal for 30 mins): 78%ee; 25.0 min (major) and 26.9 min 
(minor).   
O
H
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[1R-(lα;5α,6β]-6-para t-Butylphenyl-3-oxabicyclo[3.1.0]hexan-2-one (10d) was 
obtained using the general procedure in 76% yield (35.2 mg).  [α]20D = 21 (c = 3.5, 
CHCl3).  Configuration drawn by analogy based upon optical rotation with known 
compounds in literature.40b  1H NMR (400 MHz, CDC13): δ 7.33 (d, J = 8.4 Hz, 2H), 
7.01 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.40 (d, J = 9.6 Hz, 1H), 2.53-
2.49 (m, 1H), 2.33-2.31 (m, 2H), 1.30 (s, 9H).  13C NMR (100 MHz, CDC13): δ 175.3, 
150.5, 134.4, 126.0, 125.9, 70.00, 34.76, 31.51, 29.38, 27.54, 26.29. IR (neat, cm-1): 2964 
(C-H), 2868 (C-H), 1746 (C=O).  HRMS (ESI): Calcd. for C15H19O2 ([M+H]+) m/z 
231.1385, Found 231.1389.  GC/MS: Chiraldex G-TA (initial temperature: 150 oC; 
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isothermal for 60 mins; temperature increased 4.0 oC per min to a final temperature of 
180 oC; isothermal for 30 mins): 26%ee; 68.0 min (major) and 69.4 min (minor).   
 
[1R-(lα;5α,6β]-6-para Methoxyphenyl-3-oxabicyclo[3.1.0]hexan-2-one (10e) was 
obtained using the general procedure in 88% yield (36.1 mg).  [α]20D = 62 (c = 0.72, 
CHCl3).  Configuration drawn by analogy based upon optical rotation with known 
compounds in literature.40b  1H NMR (400 MHz, CDC13): δ 7.00 (d, J = 8.4 Hz, 2H), 
6.84 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.4, 9.6 Hz, 1H), 4.39 (d, J = 9.6 Hz, 1H), 2.49-
2.46 (m, 1H), 2.29-2.25 (m, 2H).  13C NMR (100 MHz, CDC13): δ 175.1, 158.7, 129.0, 
127.1, 114.1, 69.69, 55.29, 28.91, 27.18, 25.72. IR (neat, cm-1): 2927 (C-H), 2851 (C-H), 
1760 (C=O).  HRMS (ESI): Calcd. for C12H13O3 ([M+H]+) m/z 205.0864, Found 
205.0868.  GC/MS: Chiraldex G-TA (initial temperature: 150 oC; isothermal for 60 mins; 
temperature increased 4.0 oC per min to a final temperature of 180 oC; isothermal for 30 
mins): 70%ee; 66.1 min (major) and 67.8 min (minor).  
O
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[1R-(lα;5α,6β]-6-para Bromophenyl-3-oxabicyclo[3.1.0]hexan-2-one (10f) was 
obtained using the general procedure in 84% yield (42.3 mg).  [α]20D = 54 (c = 0.70, 
 74
CHCl3).  Configuration drawn by analogy based upon optical rotation with known 
compounds in literature.40b  1H NMR (400 MHz, CDC13): δ 7.42 (d, J = 8.4 Hz, 2H), 
6.93 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.40 (d, J = 9.6 Hz, 1H), 2.52-
2.48 (m, 1H), 2.31-2.26 (m, 2H).  13C NMR (100 MHz, CDC13): δ 174.5, 136.2, 131.8, 
127.6, 120.9, 69.58, 28.69, 27.23, 26.09. IR (neat, cm-1): 2922 (C-H), 2852 (C-H), 1743 
(C=O).  HRMS (ESI): Calcd. for C11H10BrO2 ([M+H]+) m/z 252.9864, Found 252.9869.  
GC/MS: Chiraldex G-TA (initial temperature: 150 oC; isothermal for 60 mins; 
temperature increased 4.0 oC per min to a final temperature of 180 oC; isothermal for 30 
mins): 83%ee; 75.9 min (major) and 79.3 min (minor).   
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[1S-(lα;5α,6β]-6-Furyl-3-oxabicyclo[3.1.0]hexan-2-one (10g) was obtained using the 
general procedure in 77% yield (25.3 mg).  [α]20D = 85 (c = 0.36, CHCl3).  Configuration 
drawn by analogy based upon optical rotation with known compounds in literature.40b  1H 
NMR (400 MHz, CDC13): δ 7.25 (d, J = 1.2 Hz, 1H), 6.29-6.27 (m, 1H), 6.12 (d, J = 3.2 
Hz, 1H), 4.42 (dd, J = 4.8, 9.6 Hz, 1H), 4.36 (d, J = 9.6 Hz, 1H), 2.63-2.60 (m, 1H), 2.42-
2.40 (m, 1H), 2.34-2.32 (m, 1H). 13C NMR (100 MHz, CDC13): δ 174.4, 149.9, 141.7, 
110.6, 106.3, 69.28, 25.15, 24.03, 22.73. IR (neat, cm-1): 2979 (C-H), 2910 (C-H), 1762 
(C=O).  HRMS (ESI): Calcd. for C9H9O3 ([M+H]+) m/z 165.0551, Found 165.0549.  
GC/MS: Chiraldex G-TA (initial temperature: 150 oC; isothermal for 60 mins; 
temperature increased 4.0 oC per min to a final temperature of 180 oC): 63%ee; 8.8 min 
(major) and 9.8 min (minor).    
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(1S,5R,6R)-6-methyl-6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one (10h) was obtained 
using the general procedure in 86% yield (32.5 mg).  [α]20D = 71 (c = 0.46, CHCl3).  
Configuration drawn by analogy based upon optical rotation with known compounds in 
literature.40b  1H NMR (400 MHz, CDC13): 7.33-7.21 (m, 5H),  δ 4.51 (dd, J = 5.2, 10.0 
Hz, 1H), 4.34 (d, J = 10.0 Hz, 1H), 2.53-2.50 (m, 1H), 2.44-2.43 (m, 1H), 1.46 (s, 3H).  
13C NMR (100 MHz, CDC13): δ 174.4, 143.3, 128.7, 127.2, 127.1, 66.54, 31.02, 30.63, 
29.32, 15.59.  IR (neat, cm-1): 2980 (C-H), 2902 (C-H), 1762 (C=O).  HRMS (ESI): 
Calcd. for C12H13O2 ([M+H]+) m/z 189.0916, Found 189.0922.  GC/MS: Chiraldex G-TA 
(initial temperature: 150 oC; isothermal for 60 mins; temperature increased 4.0 oC per min 
to a final temperature of 180 oC; isothermal for 30 mins): 79%ee; 16.9 min (minor) and 
18.0 min (major).    
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(1S,5R)-6,6-Dimethyl-3-oxabicyclo[3.1.0]hexan-2-one (10i) was obtained using the 
general procedure in 35% yield (9.0 mg).  [α]20D = 67 (c = 0.15, CHCl3).  Configuration 
drawn is based upon optical rotation and comparison with literature.40b  1H NMR (400 
MHz, CDC13): δ 4.35 (dd, J = 5.6, 10.0 Hz, 1H), 4.15 (d, J = 10.0 Hz, 1H), 2.05-2.02 (m, 
1H), 1.95-1.94 (m, 1H), 1.18 (s, 3H), 1.17 (s, 3H).  13C NMR (100 MHz, CDC13): δ 
174.9, 66.52, 30.49, 30.02, 25.20, 14.40.  IR (neat, cm-1): 2980 (C-H), 2902 (C-H), 1766 
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(C=O).  HRMS (ESI): Calcd. for C9H9O3 ([M+H]+) m/z 127.0759, Found 127.0748.  
GC/MS: Chiraldex G-TA (initial temperature: 150 oC; isothermal for 3 mins; temperature 
increased 5.0 oC per min to a final temperature of 180 oC; isothermal for 11 mins): 
90%ee; 20.9 min (minor) and 22.3 min (major).    
6.3. Supporting Information for Chapter 3 
 An oven dried Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, was charged with succinimidyl diazoacetate (0.37 mmol), catalyst (0.0125 
mmol).  The Schlenk tube was then evacuated and back filled with nitrogen.  The Teflon 
screw cap was replaced with a rubber septum and 0.2 ml portion of solvent was added 
followed by styrene (0.25 mmol), and the remaining solvent (total 1 mL).  The Schlenk 
tube was then purged with nitrogen for 1 minute and the rubber septum was replaced with 
a Teflon screw cap.  The Schlenk tube was then placed in an oil bath for the desired time 
and temperature.  Following completion of the reaction, the reaction mixture was purified 
by flash chromatography (hexanes:ethyl acetate = 1:1).  The fractions containing product 
were collected and concentrated by rotary evaporation to afford the compound. In most 
cases, the product was visualized on TLC using the cerium ammonium molybdate 
(CAM) stain.  
 
2,5-dioxopyrrolidin-1-yl 2-phenylcyclopropanecarboxylate (56a) was obtained using 
the general procedure in 86% yield (56.0 mg). [α]20D = -235 (c = 0.83, CHCl3). 1H NMR 
(400 MHz, CDC13): δ 7.31-7.22 (m, 3H), 7.13-7.11 (m, 2H), 2.82 (bs, 4H), 2.75-2.70 (m, 
 77
1H), 2.15-2.11 (m, 1H), 1.80-1.75 (m, 1H), 1.61-1.56 (m, 1H).  13C NMR (100 MHz, 
CDC13): δ 169.0, 168.7, 138.3, 128.6, 127.1, 126.3, 28.23, 25.57, 20.87, 18.37. IR (neat, 
cm-1): 2980 (C-H), 2890 (C-H), 1800 (C=O), 1773 (C=O), 1732 (C=O).  HRMS (ESI): 
Calcd. for C14H13NO4Na ([M+Na]+) m/z 282.07368, Found 282.07304.  HPLC Chiralcel 
OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 92%ee; 25 min (minor) and 29 min 
(major).   
 
2,5-dioxopyrrolidin-1-yl 2-p-tolylcyclopropanecarboxylate (56b) was obtained using 
the general procedure in 90% yield (61.7 mg).  [α]20D = -296 (c = 1.00, CHCl3).  1H NMR 
(400 MHz, CDC13): δ 7.11 (d, J = 7.8 Hz, 2H), 7.03 (d, J = 7.8 Hz, 2H), 2.82 (bs, 4H), 
2.74-2.69 (m, 1H), 2.32 (s, 3H), 2.12-2.08 (m, 1H), 1.78-1.73 (m, 1H), 1.59-1.54 (m, 
1H).  13C NMR (100 MHz, CDC13): δ 169.1, 168.7, 136.7, 135.2, 129.2, 126.2, 28.03, 
25.53, 20.78, 20.77, 18.23. IR (neat, cm-1): 2924 (C-H), 1783 (C=O), 1735 (C=O).  
HRMS (ESI): Calcd. for C15H19N2O4 ([M+NH4]+) m/z 291.13393, Found 291.13339.  
HPLC Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 95%ee; 20 min 
(minor) and 26 min (major).   
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The X-ray intensities were measured using Bruker-APEX2 area-detector CCD diffractometer 
(CuKa, λ = 1.54178 Å). Indexing was performed using APEX2. Frames were integrated with 
SAINT V7.51A software package. Absorption correction was performed by multi-scan 
method implemented in SADABS. The structure was solved using SHELXS-97 and refined 
using SHELXL-97 contained in SHELXTL v6.10 and WinGX v1.70.01 programs 
packages.The X-ray Crystal data and refinement conditions are shown in Table 6.1. 
Table 6.1. Crystal data and structure refinement for 56b. 
 
 
Empirical formula  C15 H15 N O4 
Formula weight  273.28 
Temperature  296(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 5.8676(2) Å α= 90°. 
 b = 8.9556(3) Å β= 90°. 
 c = 27.5262(8) Å γ = 90°. 
Volume 1446.44(8) Å3 
Z 4 
Density (calculated) 1.255 Mg/m3 
Absorption coefficient 0.760 mm-1 
F(000) 576 
Crystal size 0.35 x 0.20 x 0.08 mm3 
Theta range for data collection 3.21 to 67.78°. 
Index ranges -6<=h<=6, -9<=k<=10, -33<=l<=31 
Reflections collected 9269 
Independent reflections 1501 [R(int) = 0.0274] 
Completeness to theta = 67.78° 96.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9417 and 0.7769 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1501 / 0 / 182 
Goodness-of-fit on F2 1.084 
Final R indices [I>2sigma(I)] R1 = 0.0392, wR2 = 0.1048 
R indices (all data) R1 = 0.0520, wR2 = 0.1103 
Absolute structure parameter 10(10) 
Largest diff. peak and hole 0.102 and -0.144 e.Å-3 
 
 79
N
O
O
O
O
t-Bu  
2,5-dioxopyrrolidin-1-yl 2-(4-tert-butylphenyl)cyclopropanecarboxylate (56c) was 
obtained using the general procedure in 80% yield (62.8 mg).  [α]20D = -269 (c = 0.59, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 7.34 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 
2H), 2.83 (bs, 4H), 2.74-2.70 (m, 1H), 2.15-2.11 (m, 1H), 1.80-1.75 (m, 1H), 1.62-1.57 
(m, 1H), 1.31 (s, 9H).  13C NMR (100 MHz, CDC13): δ 169.0, 168.7, 150.1, 135.3, 126.0, 
125.5, 34.43, 31.26, 27.97, 25.53, 20.84, 18.25. IR (neat, cm-1): 2980 (C-H), 1800 (C=O), 
1771 (C=O), 1733 (C=O).  HRMS (ESI): Calcd. for C18H21NO4 ([M+Na]+) m/z 
338.13628, Found 338.13648.  HPLC: Chiralcel OD-H (95 hexanes:5 isopropanol @ 0.8 
ml/min): 97%ee; 45 min (minor) and 50 min (major).   
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2,5-dioxopyrrolidin-1-yl 2-(4-methoxyphenyl)cyclopropanecarboxylate (56d) was 
obtained using the general procedure in 71% yield (51.8 mg).  [α]20D = -300 (c = 0.59, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 7.07 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.8 Hz, 
2H), 3.79 (s, 3H), 2.81 (bs, 4H), 2.73-2.68 (m, 1H), 2.08-2.04 (m, 1H), 1.77-1.72 (m, 
1H), 1.57-1.52 (m, 1H).  13C NMR (100 MHz, CDC13): δ 169.1, 168.8, 158.7, 130.2, 
127.6, 114.0, 55.29, 27.81, 25.54, 20.66, 18.08.  IR (neat, cm-1): 1804 (C=O), 1775 
(C=O), 1732 (C=O).  HRMS (ESI): Calcd. for C15H19N2O5 ([M+NH4]+) m/z 307.12885, 
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Found 307.12795.  HPLC: Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 
95%ee; 27 min (minor) and 36 min (major).   
N
O
O
O
O
Cl  
2,5-dioxopyrrolidin-1-yl 2-(4-chlorophenyl)cyclopropanecarboxylate (56e) was 
obtained using the general procedure in 66% yield (48.9 mg).  [α]20D = -279 (c = 0.40, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 7.25 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.0 Hz, 
2H), 2.81 (bs, 4H), 2.71-2.66 (m, 1H), 2.11-2.07 (m, 1H), 1.79-1.74 (m, 1H), 1.56-1.51 
(m, 1H).  13C NMR (100 MHz, CDC13): δ 169.0, 169.4, 136.8, 132.8, 128.7, 127.7, 
27.47, 25.54, 20.85, 18.22.  IR (neat, cm-1): 2980 (C-H), 2890 (C-H), 1802 (C=O), 1773 
(C=O), 1730 (C=O).  HRMS (ESI): Calcd. for C14H12ClNO4Na ([M+Na]+) m/z 
316.03471, Found 316.03380.  HPLC: Chiralcel OD-H (80 hexanes:20 isopropanol @ 
0.8 ml/min): 90%ee; 25 min (minor) and 32 min (major).   
N
O
O
O
O
F3C  
2,5-dioxopyrrolidin-1-yl 2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate (56f) 
was obtained using the general procedure in 77% yield (63.6 mg).  [α]20D = -226 (c = 
0.78, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.54 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.4 
Hz, 2H), 2.81 (bs, 4H), 2.78-2.73 (m, 1H), 2.19-2.15 (m, 1H), 1.84-1.79 (m, 1H), 1.62-
1.57 (m, 1H).  13C NMR (100 MHz, CDC13): δ 169.0, 168.3, 142.4, 129.5, 126.6, 125.58, 
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125.54. 27.52, 25.53, 21.07, 18.41. 19F NMR (376 MHz, CDC13): δ -62.96.   IR (neat, 
cm-1): 2978 (C-H), 2892 (C-H), 1802 (C=O), 1778 (C=O), 1737 (C=O).  HRMS (ESI): 
Calcd. for C15H16F3N2O4 ([M+NH4]+) m/z 345.10567, Found 345.10450.  HPLC: 
Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 90%ee; 22 min (minor) and 
26 min (major). 
N
O
O
O
O
AcO  
2,5-dioxopyrrolidin-1-yl 2-(4-acetoxyphenyl)cyclopropanecarboxylate (56g) was 
obtained using the general procedure in 71% yield (56.8 mg).  [α]20D = -224 (c = 0.45, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 7.16 (d, J = 8.8 Hz, 2H), 7.03 (d, J = 8.4 Hz, 
2H), 2.83 (bs, 4H), 2.76-2.71 (m, 1H), 2.29 (s, 3H), 2.14-2.08 (m, 1H), 1.80-1.76 (m, 
1H), 1.59-1.55 (m, 1H).  13C NMR (100 MHz, CDC13): δ 169.4, 169.0, 168.6, 149.6, 
135.8, 127.5, 121.7, 27.67, 25.55, 21.06, 20.81, 18.26.  IR (neat, cm-1): 2963 (C-H), 1768 
(C=O), 1735 (C=O).  HRMS (ESI): Calcd. for C16H16NO6 ([M+H]+) m/z 318.09721, 
Found 318.09737.  HPLC: Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 
91%ee; 45 min (minor) and 57 min (major).   
N
O
O
O
OO2N
 
2,5-dioxopyrrolidin-1-yl 2-(3-nitrophenyl)cyclopropanecarboxylate (56h) was 
obtained using the general procedure in 50% yield (38.3 mg).  [α]20D = -150 (c = 0.19, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 8.11-8.09 (m, 1H), 7.97 (s, 1H), 7.51-7.47 (m, 
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2H), 2.85-2.80 (m, 5H), 2.26-2.21 (m, 1H), 1.90-1.85 (m, 1H), 1.62-1.63 (m, 1H).  13C 
NMR (100 MHz, CDC13): δ 168.9, 168.1, 148.4, 140.5, 132.9, 129.6, 122.1, 121.0, 
27.13, 25.54, 21.11, 18.33.  IR (neat, cm-1): 1808 (C=O), 1775 (C=O), 1731 (C=O), 1528 
(NO2), 1350 (NO2).  HRMS (ESI): Calcd. for C14H16N3O6 ([M+NH4]+) m/z 322.10336, 
Found 322.10345.  HPLC: Chiralcel AD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 
92%ee; 40 min (minor) and 47 min (major). 
N
O
O
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2,5-dioxopyrrolidin-1-yl 2-(naphthalen-2-yl)cyclopropanecarboxylate (56i) was 
obtained using the general procedure in 33% yield (25.6 mg).  [α]20D = -286 (c = 1.06, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 7.81-7.76 (m, 3H), 7.61 (s, 1H), 7.49-7.42 (m, 
2H), 7.24-7.22 (m, 1H), 2.94-2.89 (m, 1H), 2.83 (bs, 4H), 2.26-2.22 (m, 1H), 1.88-1.83 
(m, 1H), 1.74-1.69 (m, 1H).  13C NMR (100 MHz, CDC13): δ 169.1, 168.7, 135.6, 133.2, 
132.5, 128.4, 127.6, 127.5, 126.4, 125.8, 125.2, 124.4, 28.48, 25.56, 20.82, 18.27.  IR 
(neat, cm-1): 2980 (C-H), 1802 (C=O), 1774 (C=O), 1739 (C=O).  HRMS (ESI): Calcd. 
for C18H19N2O4 ([M+NH4]+) m/z 327.13393, Found 327.13379.  HPLC: Chiralcel AD-H 
(80 hexanes:20 isopropanol @ 0.8 ml/min): 91%ee; trans: 59 min (minor) and 92 min 
(major). 
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1-(2,5-dioxopyrrolidin-1-yl) 2-ethyl cyclopropane-1,2-dicarboxylate (56j) was 
obtained using the general procedure in 57% yield (36.6 mg).  [α]20D = -235 (c = 0.08, 
CHCl3).  [α]20D = -90 (c = 3.8 mg/mL, CHCl3).  1H NMR (400 MHz, CDC13): δ 4.17 (q, 
J = 7.2 Hz, 2H), 2.82 (bs, 4H), 2.45-2.41 (m, 1H), 2.37-2.33 (m, 1H), 1.67-1.57 (m, 2H), 
1.28 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDC13): δ 170.5, 168.8, 167.5, 61.53, 
25.50, 23.71, 19.05, 16.69, 14.07.  IR (neat, cm-1): 2984 (C-H), 1781 (C=O), 1727 
(C=O).  HRMS (ESI): Calcd. for C11H14NO6 ([M+H]+) m/z 256.08156, Found 
256.08129.  HPLC: Chiralcel AD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 89%ee; 
13 min (minor) and 16 min (major). 
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2,5-dioxopyrrolidin-1-yl 2-(dimethylcarbamoyl)cyclopropanecarboxylate (56k) was 
obtained using the general procedure in 52% yield (33.4 mg).  [α]20D = -101 (c = 0.16, 
CHCl3).  1H NMR (400 MHz, CDC13): δ 3.17 (s, 3H), 2.97 (s, 3H), 2.82 (bs, 4H), 2.51-
2.47 (m, 1H), 2.45-2.40 (m, 1H), 1.70-1.65 (m, 1H), 1.56-1.51 9m, 1H).  13C NMR (100 
MHz, CDC13): δ  168.9, 168.6, 168.4, 37.27, 35.96, 25.52, 22.66, 18.77, 16.31.  IR (neat, 
cm-1): 2924 (C-H), 2854 (C-H), 1782 (C=O), 1740 (C=O), 1637 (C=O).  HRMS (ESI): 
Calcd. for C11H18N3O5 ([M+NH4]+) m/z 272.12410, Found 272.12386.  HPLC: Chiralcel 
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AD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 96%ee; 19 min (minor) and 36 min 
(major). 
O
N
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2,5-dioxopyrrolidin-1-yl 2-acetylcyclopropanecarboxylate (56l) was obtained using 
the general procedure in 55% yield (31.1 mg).  [α]20D = -231 (c = 0.25, CHCl3).  1H NMR 
(400 MHz, CDC13): δ 2.81 (bs, 4H), 2.65-2.60 (m, 1H), 2.45-2.41 (m, 1H), 2.35 (s, 3H), 
1.60-1.56 (m, 2H).  13C NMR (100 MHz, CDC13): δ 203.9, 168.8, 167.6, 30.99, 30.37, 
25.51, 20.63, 18.30.  IR (neat, cm-1): 2924 (C-H), 1780 (C=O), 1735 (C=O), 1704 (C=O).  
HRMS (ESI): Calcd. for C10H11NO5Na ([M+Na]+) m/z 248.05294, Found 248.05239.   
HPLC: Chiralcel AD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 91%ee; 22 min 
(minor) and 39 min (major). 
 
N-hexyl-2-phenylcyclopropanecarboxamide (57a) was obtained in 92% yield (29.1 
mg).  [α]20D = -242 (c = 0.49, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.25-7.22 (m, 
2H), 7.17-7.15 (m, 1H), 7.06-7.04 (m, 2H), 5.65 (bs, 1H), 3.26-3.22 (m, 2H), 2.45-2.43 
(m, 1H), 1.58-1.51 (m, 2H), 1.47-1.45 (m, 2H), 1.26 (bs, 6H), 1.21-1.18 (m, 1H), 0.85 
(m, 3H).  13C NMR (100 MHz, CDC13): δ  171.6, 140.9, 128.4, 126.1, 125.9, 39.86, 
31.44, 29.64, 26.81, 26.57, 24.85, 22.51, 15.80, 13.97.   IR (neat, cm-1): 3295 (N-H), 
2956 (C-H), 2925 (C-H), 2857 (C-H), 1634 (C=O).  HRMS (ESI): Calcd. for C16H24NO 
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([M+H]+) m/z 246.1858, Found 246.1860.  HPLC Chiralcel AD-H (80 hexanes:20 
isopropanol @ 0.8 ml/min): 90%ee; 6 min (minor) and 8 min (major). 
 
N-(4-methoxyphenyl)-2-phenylcyclopropanecarboxamide (57b) was obtained in 62% 
yield (27.4 mg).  [α]20D = -252 (c = 0.54, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.39 
(d, J = 8.0 Hz, 2H), 7.34 (bs, 1H), 7.29-7.24 (m, 2H), 7.20-7.19 (m, 1H), 7.09 (d, J = 7.6 
Hz, 2H), 6.82 (d, J = 7.6 Hz, 2H), 3.76 (s, 3H), 2.55-2.54 (m, 1H), 1.70-1.68 (m, 2H), 
1.32-1.30 (m, 1H).  13C NMR (100 MHz, CDC13): δ  170.2, 156.5, 140.8, 131.3, 128.7, 
126.5, 126.2, 121.8, 114.3, 55.69, 27.74, 25.90, 16.46.  IR (neat, cm-1): 3274 (N-H), 2980 
(C-H), 1643 (C=O).  HRMS (ESI): Calcd. for C17H18NO2 ([M+H]+) m/z 268.1337, Found 
268.1337.  HPLC Chiralcel AD-H (90 hexanes:10 isopropanol @ 1.0 ml/min): 89%ee; 16 
min (major) and 28 min (minor). 
 
2-phenylcyclopropanecarboxamide (57c) was obtained in 93% yield (29.6 mg).  [α]20D 
= -290 (c = 0.14, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.25-7.22 (m, 2H), 7.19-7.16 
(m, 1H), 7.08-7.05 (m, 2H), 5.82-5.71 (bd, 2H), 2.49-2.45 (m, 1H), 1.68-1.61 (m, 1H), 
1.60-1.56 (m, 1H), 1.27-1.23 (m, 1H).  13C NMR (100 MHz, CDC13): δ  174.1, 140.5, 
128.4, 126.3, 126.0, 25.83, 25.66, 16.29.  IR (neat, cm-1): 3382 (N-H), 3201 (N-H), 2922 
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(C-H), 1647 (C=O).  HRMS (ESI): Calcd. for C10H12NO ([M+H]+) m/z 162.09134, 
Found 162.09066.  HPLC Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 
94%ee; 8 min (major) and 10 min (minor).   
 
(2-phenylcyclopropyl)(pyrrolidin-1-yl)methanone (57d) was obtained in 91% yield 
(32.4 mg).  [α]20D = -376 (c = 0.30, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.27-7.23 
(m, 2H), 7.18-7.14 (m, 1H), 7.11-7.09 (m, 2H), 3.61-3.53 (m, 2H), 3.48 (t, J = 6.8 Hz, 
2H), 2.52-2.47 (m, 1H), 1.97 -1.81 (m, 5H), 1.65-1.61 (m, 1H), 1.25-1.21 (m, 1H).  13C 
NMR (100 MHz, CDC13): δ  170.4, 141.2, 128.3, 126.1 (2 Ar), 46.58, 46.01, 25.99, 
25.39, 24.58, 24.40, 16.26.  IR (neat, cm-1): 2979 (C-H), 2873 (C-H), 1607 (C=O).  
HRMS (ESI): Calcd. for C14H18NO ([M+H]+) m/z 216.13829, Found 216.13775.  HPLC 
Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 92%ee; 7 min (minor) and 8 
min (major).   
 
morpholino(2-phenylcyclopropyl)methanone (57e)  was obtained in 95% yield (40.9 
mg). [α]20D = -178 (c = 0.48, CHCl3).  1H NMR (400 MHz, CDC13): δ 7.28-7.25 (m, 2H), 
7.20-7.16 (m, 1H), 7.10-7.08 (m, 2H), 3.66-3.61 (m, 8H), 2.50-2.45 (m, 1H), 1.93-1.89 
(m, 1H), 1.69-1.63 (m, 1H), 1.30-1.24 (m, 1H).  13C NMR (100 MHz, CDC13): δ  170.6, 
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140.7, 128.4, 126.3, 125.9, 66.78 (2 C), 45.95, 42.53, 25.52, 22.91, 16.15.  IR (neat, cm-
1): 2980 (C-H), 2890 (C-H), 1632 (C=O).  HRMS (ESI): Calcd. for C14H18NO2 ([M+H]+) 
m/z 232.13321, Found 232.13339.  HPLC Chiralcel OD-H (80 hexanes:20 isopropanol 
@ 0.8 ml/min): 92%ee; 11 min (minor) and 17 min (major).   
 
(2S)-methyl 3-phenyl-2-(2-phenylcyclopropanecarboxamido)propanoate (57f) was 
obtained in 66% yield (17.3 mg).  [α]20D = -46 (c = 0.34, CHCl3).  1H NMR (400 MHz, 
CDC13): δ 7.29-7.17 (m, 6H), 7.08-7.06 (m, 4H), 6.10 (d, J = 7.6 Hz, 1H), 4.94-4.89 (m, 
1H), 3.71 (s, 3H), 3.18-3.06 (m, 2H), 2.48-2.43 (m, 1H), 1.60-1.57 (m, 2H), 1.26-1.22 
(m, 1H).  13C NMR (100 MHz, CDC13): δ  172.1, 171.4, 140.5, 135.7, 129.2, 128.5, 
128.4, 127.1, 126.3, 126.1, 53.28, 52.30, 37.99, 26.38, 25.41, 15.82.  IR (neat, cm-1): 
3312 (N-H), 3033 (C-H), 2950 (C-H), 1741 (C=O), 1639 (C=O).  HRMS (ESI): Calcd. 
for C20H22NO3 ({M+H]+) m/z 324.1599, Found 324.1597.   
 
N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2-phenylcyclopropanecarboxamide (57g) 
was obtained in 93% yield (20.8 mg).  [α]20D = -161 (c = 0.40, CHCl3).  1H NMR (400 
MHz, CDC13): δ 7.29-7.16 (m, 8H), 7.05-7.03 (m, 2H), 6.00 (d, J = 28.8 Hz, 1H), 4.19-
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4.17 (m, 1H), 3.68-3.66 (m, 1H), 3.59-3.55 (m, 1H), 2.91 (bs, 1H), 2.86 (d, J = 7.2 Hz, 
2H), 2.45-2.40 (m, 1H), 1.60-1.53 (m, 2H), 1.24-1.18 (m, 1H).  13C NMR (100 MHz, 
CDC13): δ  172.5, 140.5, 137.5, 129.2, 128.6, 128.4, 126.6, 126.2, 126.0, 64.01, 53.14, 
37.07, 26.63, 25.16, 15.94.  IR (neat, cm-1): 3284 (O-H, N-H), 2954 (C-H), 1633 (C=O).  
HRMS (ESI): Calcd. for C19H22NO2 ([M+H]+) m/z 296.1650, Found 296.1645. 
 
N-((R)-1-hydroxy-3-methylbutan-2-yl)-2-phenylcyclopropanecarboxamide (57h) was 
obtained in 54% yield (11.2 mg).  [α]20D = -156 (c = 0.22, CHCl3).  1H NMR (400 MHz, 
CDC13): δ 7.27-7.23 (m, 2H), 7.19-7.17 (m, 1H), 7.07-7.05 (m, 2H), 5.87 (d, J = 7.2 Hz, 
1H), 3.74-3.72 (m, 1H), 3.65-3.64 (m, 2H), 2.78 (bs, 1H), 2.47-2.44 (m ,1H), 1.63-1.60 
(m, 2H), 1.24-1.21 (m, 1H), 0.945 (m, 6H).  13C NMR (100 MHz, CDC13): δ  172.9, 
140.7, 128.4, 126.2, 125.9, 64.21, 57.56, 29.13, 26.78, 25.21, 19.43, 18.75, 16.17.  IR 
(neat, cm-1): 3287 (O-H, N-H), 2924 (C-H), 1637 (C=O).  HRMS (ESI): Calcd. for 
C15H22NO2 ({M+H]+) m/z 248.1650, Found 248.1657. 
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N-(2-phenylcyclopropanecarboxamido)-D-glucosamine (57i) was obtained in 47 % 
yield (20.4 mg) as a mixture of anomers (α:β = 1.6:1) as determined by HPLC.  The 
product was purified by preparatory HPLC using a Dionex Summit HPLC equipped with 
the Supelcosil PLC-8 column (250 mm x 21.2 mm, 12 micron particle size, C8) utilizing 
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a gradient solvent system of acetonitrile in water (5% MeCN:H2O – 30% MeCN:H2O) 
with a flow rate of 20 ml/min.  [α]20D = -51 (c = 0.78, DMSO).  1H NMR (400 MHz, 
DMSO) (anomeric mixture α:β = 2:1): δ 8.02 (d, J = 8.4 Hz, 1H, β anomer), 7.95 (d, J = 
8.0 Hz, 1H, α anomer), 7.29-7.25 (m, 2H, anomeric mixture), 7.18-7.14 (m, 1H, anomeric 
mixture), 7.10-7.09 (m, 2H, anomeric mixture), 6.52 (d, J = 6.4 Hz, 1H, β anomer), 6.41 
(d, J = 4.4 Hz, 1H, α anomer), 4.94-4.92 (m, 1H, mixture of anomers), 4.88 (d, J = 5.6 
Hz, 1H, α anomer), 4.85 (d, J = 5.6 Hz, 1H, β anomer), 4.65 (d, J = 5.6 Hz, 1H, α 
anomer), 4.50 (t, J = 5.6 Hz, 1H, β anomer), 4.45-4.40 (m, 1H), 3.69-3.56 (m, 2H, 
anomeric mixture), 3.53-3.30 (m, 3H, anomeric mixture), 3.27 (m, 1H, β anomer), 3.11 
(m, 1H, α anomer), 3.05 (m, 1H, anomeric mixture), 2.26-2.18 (m, 1H, anomeric 
mixture), 2.13-2.09 (m, 1H, α anomer), 1.89-1.85 (m, 1H, β anomer), 1.36-1.30 (m, 1H, 
anomeric mixture), 1.20-1.10 (m, 1H, anomeric mixture). 13C NMR (100 MHz, DMSO) 
(α anomer): δ  171.1, 141.3, 128.3 (2), 125.8, 125.7 (2), 90.58, 72.05, 71.22, 70.50, 
61.14, 54.47, 25.32, 23.83, 15.59.  13C NMR (100 MHz, DMSO) (β anomer): δ  171.13, 
141.3, 128.3 (2), 125.8, 125.7 (2), 95.49, 76.77, 74.45, 70.88, 61.14, 57.39, 26.11, 23.83, 
15.59. IR (neat, cm-1): 3285 (O-H, N-H), 1637 (C=O), 1613 (C=O), 1563 (C=C).  HRMS 
(ESI): Calcd. for C16H22NO6 ([M+H]+) m/z 324.1447, Found 324.1469.    
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Figure 6.1. Carbon Assignments for the α- and β-Anomer of 57i. 
 
2-(2-(2-(2-phenylcyclopropanecarboxamido)acetamido)acetamido)propanoic acid2 
(57j) was obtained in 60% yield (30.8 mg). The cyclopropyl peptide was purified by 
preparatory HPLC using a Dionex Summit HPLC equipped with the Waters Radial 
Compression column (300 mm x 25 mm, 15 micron particle size, 300 Angstrom pore 
size, C4) utilizing a gradient solvent system of acetonitrile and water (5% MeCN/H20 – 
50%MeCN/H20) with a flow rate of 20 ml/min.  [α]20D = -185 (c = 0.19, IPA).  1H NMR 
(400 MHz, D2O): δ 7.24-7.20 (m, 2H), 7.15- 7.12 (m, 1H), 7.09-7.08 (m, 2H), 4.24 (t, J = 
7.6 Hz, 1H), 3.84-3.82 (m, 4H), 2.36-2.31 (m, 1H), 1.88-1.83 (m, 1H), 1.42-1.37 (m, 1H), 
1.32-1.25 (m, 4 H). 13C NMR (100 MHz, D2O): δ  179.4, 178.9, 175.1, 173.7, 143.1, 
131.4, 129.3, 128.8, 51.55, 45.67, 44.86, 28.26, 27.69, 18.95, 18.32.  IR (neat, cm-1): 
3303 (O-H, N-H), 2979 (C-H), 1651 (C=O), 1635 (C=O).  HRMS (ESI): Calcd. for 
C17H22N3O5 ([M+H]+) m/z 348.1559, Found 348.1550.  
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6.4. Supporting Information for Chapter 4 
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Porphyrin 7 (P7). An oven-dried Schlenk tube equipped with a stirring bar was degassed 
on vacuum line and purged with nitrogen. The tube was then charged with 5,15-Bis(2,6-
dibromophenyl)-10,20-bis[3,5-di(tert-butyl)phenyl]porphyrin1 ( 0.2 mmol, 1 eq), 
isobutylamide (3.2 mmol, 16 eq), Pd(OAc)2 (0.08 mmol, 40%), Xantphos (0.16 mmol, 
80%), Cs2CO3 (3.2 mmol, 16 eq).  The tube was capped with a Teflon screw cap, 
evacuated and backfilled with nitrogen. After the Teflon screw cap was replaced with a 
rubber septum, solvent (4-5 mL) was added via syringe. The tube was purged with 
nitrogen (1-2 min) and the septum was then replaced with the Teflon screw cap and 
sealed. The reaction mixture was heated in an oil bath at 100 oC with stirring for 72 
hours.  The resulting reaction mixture was concentrated and the solid residue was purified 
by flash chromatography (hexanes: ethyl acetate, 7: 3) to afford the compound as a purple 
solid (65 - 75%, in general).  1H NMR (400 MHz, CDC13): δ  8.97 (d, J = 4.4 Hz, 4H), 
8.85 (d, J = 4.8 Hz, 4H), 8.48 (d, J = 7.6 Hz, 4H), 8.00 (s, 4H), 7.90-7.85 (m, 4H), 6.46 
(s, 4H), 1.52 (s, 36H), 1.20 (m, 4H), 0.31 (d, J = 7.4 Hz, 24H), -2.53 (s, 2H). 13C NMR 
(125 MHz, CDC13): δ 174.7, 149.4, 139.7, 138.8, 133.5, 130.5, 130.1, 123.1, 121.8, 
117.8, 108.0, 35.8, 35.0, 31.6, 18.5.  UV–vis (CHCl3), λmax, nm (log ε): 425(5.48), 
519(4.19), 555(3.84), 595(3.70), 650(3.60).  HRMS (ESI): Calcd. for C76H91N8O4 
([M+H]+) m/z 1179.71578, Found 1179.71870. 
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[Co(P7)] Porphyrin Complex.  Porphyrin 7 (0.054 mmol) and anhydrous CoCl2 (0.43 
mmol) were placed in an oven-dried, re-sealable Schlenk tube. The tube was capped with 
a Teflon screw-cap, evacuated, and backfilled with nitrogen. The screw cap was replaced 
with a rubber septum, 2,6-lutidine (0.25 mmol) and dry THF (3-4 mL) were added via 
syringe. The tube was purged with nitrogen for 1-2 minutes, and then the septum was 
replaced with the Teflon screw cap. The tube was sealed, and its contents were heated in 
an oil bath at 80 oC with stirring overnight. The resulting mixture was cooled to room 
temperature, taken up in ethyl acetate, and transferred to a separatory funnel. The mixture 
was washed with water 3 times and concentrated.  The solid residue was purified by flash 
chromatography (hexanes: ethyl acetate, 6: 4) to afford the compound as a purple solid 
(55.3 mg, 83% ).  UV–vis (CHCl3), λmax, nm (log ε): 415(5.23), 530(4.19).  HRMS (ESI): 
Calcd. for C76H88N8O4Co ([M]+) m/z 1235.62550, Found 1235.62638. 
An oven dried Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, was charged with azide (if solid, 0.2 mmol), catalyst (0.004 mmol), and 4Å 
MS (100 mg).  The Schlenk tube was then evacuated and back filled with nitrogen.  The 
Teflon screw cap was replaced with a rubber septum and 0.2 ml portion of solvent was 
added followed by styrene (1.0 mmol), another portion of solvent, then azide (if liquid, 
0.2 mmol), and the remaining solvent (total 1 mL).  The Schlenk tube was then purged 
with nitrogen for 1 minute and the rubber septum was replaced with a Teflon screw cap.  
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The Schlenk tube was then placed in an oil bath for the desired time and temperature.  
Following completion of the reaction, the reaction mixture was purified by flash 
chromatography.  The fractions containing product were collected and concentrated by 
rotary evaporation to afford the compound.  
N
S
O
O
 
2-Phenyl-1-tosylaziridine (65aa) was obtained using the general procedure as colorless 
oil in 94% yield (51.4 mg). [α]20D = -71 (c = 0.35, CHCl3). 1H NMR (400 MHz, CDC13): 
δ 7.87 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 7.31-7.27 (m, 3H), 7.20 (m, 2H), 
3.78 (dd, J = 7.2, 4.4 Hz, 1H), 2.98 (d, J = 7.2 Hz, 1H), 2.43 (s, 3H), 2.38 (d, J = 4.4 Hz, 
1H).  13C NMR (125 MHz, CDC13): δ 144.5, 134.97, 134.91, 129.6, 128.4, 128.2, 127.8, 
126.4, 40.94, 35.84, 21.55. IR (neat, cm-1): 2923, 2854, 1595, 1495, 1458, 1385, 1319, 
1307, 1290, 1232, 1188, 1155, 1134, 1117, 1093, 1082, 907, 815, 799, 780, 754, 711, 
696, 687, 662, 634.  HRMS (ESI): Calcd. for C15H16NO2S ([M+H]+) m/z 274.08963, 
Found 274.08987.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 86%ee; 
52 min (minor) and 62 min (major). 
N
S
O
O
OMe  
1-(4-Methoxyphenylsulfonyl)-2-phenylaziridine (65ba) was obtained using the general 
procedure as white solid in 88% yield (51.0 mg). [α]20D = -150 (c = 0.04, CHCl3). 1H 
NMR (400 MHz, CDC13): δ 7.92 (d, J = 8.8 Hz, 2H), 7.28 (m, 3H), 7.21 (m, 2H), 6.99 
(d, J = 8.8 Hz, 2H), 3.74 (dd, J = 7.2, 4.0 Hz, 1H), 3.87 (s, 3H), 2.96 (d, J = 7.2 Hz, 1H), 
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2.38 (d, J = 4.0 Hz, 1H). 13C NMR (125 MHz, CDC13): δ 163.6, 135.0, 130.0, 129.3, 
128.4, 128.2, 126.4, 114.2, 55.6, 40.9, 35.8.  IR (neat, cm-1): 2958, 2924, 2854, 1592, 
1576, 1498, 1458, 1442, 1322, 1301, 1259, 1192, 1150, 1116, 1093, 1017, 908, 836, 805, 
779, 755, 721, 691, 667, 629.  HRMS (ESI): Calcd. for C15H16NO3S ([M+H]+) m/z 
290.08454, Found 290.08488.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 
ml/min): 88%ee; 98 min (minor) and 113 min (major). 
N
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N-(4-(2-Phenylaziridin-1-ylsulfonyl)phenyl)acetamide (65ca) was obtained using the 
general procedure as tan solid in 98% yield (62.2 mg).  1H NMR (400 MHz, CDC13): δ 
7.90 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.4 Hz, 2H), 7.61 (bs, 1H), 7.27 (m, 3H), 7.20 (m, 
2H), 3.76 (dd, J = 7.2, 4.4 Hz, 1H), 2.97 (d, J = 7.2 Hz, 1H), 2.39 (d, J = 4.4 Hz, 1H), 
2.19 (s, 3H). 13C NMR (125 MHz, CDC13): δ 168.8, 142.9, 134.7, 132.0, 129.1, 128.5, 
128.4, 126.4, 119.2, 41.1, 36.0, 24.6.  IR (neat, cm-1): 3264, 2969, 2924, 1676, 1606, 
1587, 1540, 1496, 1400, 1369, 1323, 1265, 1158, 1093, 908, 838, 823, 805, 779, 760, 
728, 719, 697, 682, 668, 638, 623.  HRMS (ESI): Calcd. for C16H17N2O3S ([M+H]+) m/z 
317.09544, Found 317.09508. 
N
S
O
O
CN  
4-(2-Phenylaziridin-1-ylsulfonyl)benzonitrile (65da) was obtained using the general 
procedure as a white solid in 89% yield (50.8 mg). [α]20D = -227 (c = 0.25, CHCl3). 1H 
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NMR (400 MHz, CDC13): δ 8.10 (d, J = 8.4 Hz, 2H), 7.83 (d, J = 8.0 Hz, 2H), 7.30 (m, 
3H), 7.21 (m, 2H), 3.88 (dd, J = 7.2, 4.8 Hz, 1H), 3.08 (d, J = 7.2 Hz, 1H), 2.48 (d, J = 
4.8 Hz, 1H).  13C NMR (100 MHz, CDC13): δ 206.9, 142.0, 133.5, 128.3, 128.1, 126.1, 
117.0, 116.7, 41.4, 36.2.  IR (neat, cm-1): 2233, 1458, 1403, 1333, 1291, 1242, 1187, 
1162, 119, 1094, 1020, 973, 909, 844, 797, 758, 749, 724, 699, 682, 644, 624.  HRMS 
(ESI): Calcd. for C15H13N2O2S ([M+H]+) m/z 285.06922, Found 285.07029.  HPLC: 
Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 87%ee; 71 min (minor) and 86 
min (major). 
N
S
O
O
NO2  
1-(4-Nitrophenylsulfonyl)-2-phenylaziridine (65ea) was obtained using the general 
procedure as a white solid in 97% yield (58.9 mg). [α]20D = -286 (c = 0.42, CHCl3). 1H 
NMR (400 MHz, CDC13): δ 8.37 (d, J = 8.8 Hz, 2H), 8.19 (d, J = 8.8 Hz, 2H), 7.31 (m, 
3H), 7.22 (m, 2H), 3.90 (dd, J = 7.2, 4.4 Hz, 1H), 3.11 (d, J = 7.6 Hz, 1H), 2.50 (d, J = 
4.4 Hz, 1H). 13C NMR (125 MHz, CDC13): δ 150.6, 143.9, 134.1, 129.1, 128.7, 128.1, 
126.4, 124.3, 41.8, 36.5.  IR (neat, cm-1): 3110, 2923, 1607, 1527, 1461, 1348, 1307, 
1292, 1192, 1157, 1093, 977, 908, 866, 858, 811, 774, 759, 745, 707, 691, 680, 619.  
HRMS (ESI): Calcd. for C14H13N2O4S ([M+H]+) m/z 305.05905, Found 305.05901.  
HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 88%ee; trans: 47 min 
(minor) and 58 min (major). 
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1-(2-Nitrophenylsulfonyl)-2-phenylaziridine (65fa) was obtained using the general 
procedure as tan oil in 96% yield (58.5 mg). [α]20D = -49 (c = 0.40, CHCl3). 1H NMR 
(400 MHz, CDC13): δ 8.23 (d, J = 6.4 Hz, 1H), 7.74 (m, 3H), 7.32 (m, 5H), 3.76 (m, 1H), 
3.24 (d, J = 7.6 Hz, 1H), 2.63 (d, J = 4.4 Hz, 1H). 13C NMR (125 MHz, CDC13): δ 148.5, 
134.6, 134.4, 132.1, 131.9, 131.2, 128.59, 128.56, 126.5, 124.3, 42.8, 38.0.  IR (neat, cm-
1): 3094, 2921, 1540, 1461, 1365, 1331, 1192, 1163, 1126, 1066, 1017, 979, 908, 851, 
774, 750, 745, 697, 654, 631.  HRMS (ESI): Calcd. for C14H13N2O4S ([M+H]+) m/z 
305.05905, Found 305.05928.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 
ml/min): 70%ee; 72 min (minor) and 100 min (major). 
N
S
O
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1-(Naphthalen-1-ylsulfonyl)-2-phenylaziridine (65ga) was obtained using the general 
procedure as white solid in 97% yield (60.0 mg).  1H NMR (400 MHz, CDC13): δ 9.00 
(d, J = 8.4 Hz, 1H), 8.27 (d, J = 7.2 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H), 7.93 (d, J = 8.0 Hz, 
1H), 7.70 (t, J = 7.6 Hz, 1H), 7.61 (t, J = 7.6 Hz, 1H), 7.55 (t, J = 8.0 Hz, 1H), 7.25 (m, 
3H), 7.20 (m, 2H), 3.76 (m, 1H), 3.09 (d, J = 7.2 Hz, 1H), 2.38 (d, J = 4.4 Hz, 1H). 13C 
NMR (125 MHz, CDC13): δ 135.17, 135.14, 134.1, 133.3, 129.4, 129.0, 128.6, 128.4, 
128.27, 128.22, 127.0, 126.4, 125.7, 123.9, 41.1, 36.7.  IR (neat, cm-1): 3060, 1594, 1507, 
1459, 1384, 1319, 1191, 1161, 1132, 1110, 1083, 1027, 976, 906, 831, 803, 768, 708, 
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694, 672, 627, 601.  HRMS (ESI): Calcd. for C18H16NO2S ([M+H]+) m/z 310.08963, 
Found 310.08908. 
N
S
O
O
NO2  
1-(4-Nitrophenylsulfonyl)-2-p-tolylaziridine (65eb) was obtained using the general 
procedure as tan solid in 89% yield (56.5 mg). [α]20D = -167 (c = 0.37, CHCl3). 1H NMR 
(400 MHz, CDC13): δ 8.36 (d, J = 8.8 Hz, 2H), 8.17 (d, J = 8.8 Hz, 2H), 7.10 (m, 4H), 
3.86 (dd, J = 7.2, 4.8 Hz, 1H), 3.10 (d, J = 7.2 Hz, 1H), 2.50 (d, J = 4.8 Hz, 1H), 2.31 (s, 
3H).  13C NMR (125 MHz, CDC13): δ 150.6, 144.0, 138.6, 131.0, 129.4, 129.1, 126.3, 
124.3, 41.9, 36.4, 21.1.  IR (neat, cm-1): 3109, 2958, 1606, 1524, 1347, 1322, 1307, 1290, 
1157, 1190, 1092, 977, 912, 866, 855, 817, 794, 752, 746, 729, 697, 679, 668, 611.  
HRMS (ESI): Calcd. for C15H15N2O4S ([M+H]+) m/z 319.07470, Found 319.07413.  
HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 81%ee; 47 min (minor) 
and 59 min (major). 
N
S
O
O
NO2  
1-(4-Nitrophenylsulfonyl)-2-m-tolylaziridine (65ec) was obtained using the general 
procedure as tan solid in 89% yield (57.0 mg). [α]20D = -269 (c = 0.30, CHCl3).  1H NMR 
(400 MHz, CDC13): δ 8.37 (d, J = 8.8 Hz, 2H), 8.18 (d, J = 8.4 Hz, 2H), 7.20 (t, J = 8.0 
Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 7.01 (m, 2H), 3.86 (dd, J = 7.2, 4.8 Hz, 1H), 3.09 (d, J 
= 7.2 Hz, 1H), 2.50 (d, J = 4.8 Hz, 1H), 2.31 (s, 3H).  13C NMR (125 MHz, CDC13): δ 
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150.6, 143.9, 138.5, 134.0, 129.5, 129.1, 128.6, 127.0, 124.3, 123.5, 41.9, 36.5, 21.3.  IR 
(neat, cm-1): 3107, 2924, 1607, 1525, 1489, 1457, 1348, 1324, 1307, 1292, 1215, 1156, 
1112, 1092, 979, 930, 900, 866, 854, 807, 783, 751, 711, 688, 669, 620.  HRMS (ESI): 
Calcd. for C15H15N2O4S ([M+H]+) m/z 319.07470, Found 319.07410.  HPLC: Whelk-01 
(98 hexanes:02 isopropanol @ 1.0 ml/min): 80%ee; 42 min (minor) and 54 min (major). 
N
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1-(4-Nitrophenylsulfonyl)-2-o-tolylaziridine (65ed) was obtained using the general 
procedure as tan solid in 88% yield (56.2 mg). [α]20D = -238 (c = 0.31, CHCl3). 1H NMR 
(400 MHz, CDC13): δ 8.40 (d, J = 8.4 Hz, 2H), 8.22 (d, J = 8.4 Hz, 2H), 7.23-7.11 (m, 
3H), 7.06 (d, J = 7.6 Hz, 1H), 3.01 (m, 1H), 3.10 (d, J = 7.2 Hz, 1H), 2.43 (d, J = 4.8 Hz, 
1H), 2.41 (s, 3H).  13C NMR (125 MHz, CDC13): δ 150.6, 143.9, 136.7, 132.3, 130.1, 
129.2, 128.4, 126.2, 125.5, 124.3, 40.2, 35.8, 19.0.  IR (neat, cm-1): 2980, 1607, 1524, 
1349, 1328, 1306, 1243, 1203, 1158, 1092, 1012, 976, 907, 867, 829, 766, 744, 742, 698, 
680, 668, 621.  HRMS (ESI): Calcd. for C15H15N2O4S ([M+H]+) m/z 319.07470, Found 
319.07415.  HPLC: Chiralcel OD-H (80 hexanes:20 isopropanol @ 0.8 ml/min): 85%ee; 
60 min (minor) and 78 min (major). 
N
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NO2  
2-(4-tert-Butylphenyl)-1-(4-nitrophenylsulfonyl)aziridine (65ee) was obtained using 
the general procedure as tan oil in 98% yield (71.0 mg). [α]20D = -86 (c = 0.44, CHCl3). 
1H NMR (400 MHz, CDC13): δ 8.37 (d, J = 8.4 Hz, 2H), 8.19 (d, J = 8.4 Hz, 2H), 7.34 
 99
(d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 3.89 (m, 1H), 3.09 (d, J = 7.2 Hz, 1H), 2.51 
(d, J = 4.8 Hz, 1H), 1.28 (s, 9H).  13C NMR (125 MHz, CDC13): δ 151.9, 150.6, 144.0, 
131.0, 129.1, 126.1, 125.6, 124.3, 41.9, 36.7, 34.6, 31.2.  IR (neat, cm-1): 3060, 2964, 
1594, 1533, 1507, 1459, 1320, 1191, 1161, 1133, 1110, 1086, 1027, 977, 907, 832, 804, 
770, 744, 696, 673, 628, 604.  HRMS (ESI): Calcd. for C18H21N2O4S ([M+H]+) m/z 
361.12165, Found 361.12077.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 
ml/min): 88%ee; 47 min (minor) and 58 min (major). 
N
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Cl
 
2-(4-Chlorophenyl)-1-(4-nitrophenylsulfonyl)aziridine (65ef) was obtained using the 
general procedure as white solid in 94% yield (63.5 mg). [α]20D = -83 (c = 0.43, CHCl3). 
1H NMR (400 MHz, CDC13): δ 8.37 (d, J = 8.8 Hz, 2H), 8.17 (d, J = 8.8 Hz, 2H), 7.28 
(d, J = 8.8 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 3.87 (dd, J = 7.2, 4.8 Hz, 1H), 3.10 (d, J = 
7.2 Hz, 1H), 2.54 (d, J = 4.8 Hz, 1H).  13C NMR (125 MHz, CDC13): δ 150.6, 143.6, 
134.6, 132.7, 129.1, 128.9, 127.7, 124.3, 40.9, 36.7.  IR (neat, cm-1): 3109, 2958, 2925, 
1607, 1523, 1494, 1345, 1323, 1306, 1156, 1091, 1016, 980, 911, 867, 834, 803, 753, 
743, 724, 694, 680, 658, 630, 604.  HRMS (ESI): Calcd. for C14H12N2O4SCl ([M+H]+) 
m/z 339.02008, Found 339.02007.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 
ml/min): 82%ee; 50 min (minor) and 62 min (major). 
N
S
O
O
NO2
Br
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2-(4-Bromophenyl)-1-(4-nitrophenylsulfonyl)aziridine (65eg) was obtained using the 
general procedure as white solid in 96% yield (73.5 mg). [α]20D = -143 (c = 0.57, CHCl3). 
1H NMR (400 MHz, CDC13): δ 8.38 (d, J = 8.8 Hz, 2H), 8.18 (d, J = 8.8 Hz, 2H), 7.20 
(m, 2H), 7.00 (t, J = 8.4 Hz, 2H), 3.87 (m, 1H), 3.09 (d, J = 7.2 Hz, 1H), 2.45 (d, J = 4.4 
Hz, 1H).  13C NMR (125 MHz, CDC13): δ 150.6, 143.6, 133.2, 131.8, 129.1, 128.0, 
124.3, 122.7, 41.1, 36.6.  IR (neat, cm-1): 2979, 2924, 1607, 1532, 1491, 1336, 1348, 
1319, 1161, 1091, 1009, 981, 906, 854, 802, 769, 753, 739, 722, 688, 668, 625, 617.  
HRMS (ESI): Calcd. for C14H12N2O4SBr ([M+H]+) m/z 382.96957, Found 382.96952.  
HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 86%ee; 53 min (minor) 
and 66 min (major). 
N
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2-(4-Fluorophenyl)-1-(4-nitrophenylsulfonyl)aziridine (65eh) was obtained using the 
general procedure as white solid in 95% yield (61.5 mg). [α]20D = -255 (c = 0.47, CHCl3). 
1H NMR (400 MHz, CDC13): δ 8.38 (d, J = 8.8 Hz, 2H), 8.18 (d, J = 8.8 Hz, 2H), 7.19 
(m, 2H), 7.00 (m, 2H), 3.88 (dd, J = 7.2, 4.4 Hz, 1H), 3.09 (d, J = 7.2 Hz, 1H), 2.47 (d, J 
= 4.4 Hz, 1H).  13C NMR (125 MHz, CDC13): δ 164.1, 162.1, 144.0, 130.2, 129.4, 128.5, 
124.6, 116.1, 115.9, 41.4, 36.9.  IR (neat, cm-1): 3109, 1611, 1523, 1512, 1455, 1348, 
1323, 1308, 1292, 1231, 1187, 1157, 1120, 1092, 981, 911, 868, 836, 817, 796, 754, 746, 
734, 715, 695, 680, 611.  HRMS (ESI): Calcd. for C14H12N2O4FS ([M+H]+) m/z 
323.04963, Found 323.04920.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 
ml/min): 88%ee; 48 min (minor) and 57 min (major). 
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1-(4-Nitrophenylsulfonyl)-2-(4-(trifluoromethyl)phenyl)aziridine (65ei) was obtained 
using the general procedure as a white solid in 96% yield (71.8 mg). [α]20D = -157 (c = 
0.48, CHCl3). 1H NMR (400 MHz, CDC13): δ 8.39 (d, J = 8.4 Hz, 2H), 8.19 (d, J = 8.8 
Hz, 2H), 7.58 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 3.94 (dd, J = 7.2, 4.8 Hz, 1H), 
3.14 (d, J = 7.2 Hz, 1H), 2.48 (d, J = 4.4 Hz, 1H).  13C NMR (125 MHz, CDC13): δ 
151.0, 143.8, 138.5, 129.5, 127.1, 126.04, 126.00, 124.7, 41.1, 37.1.  IR (neat, cm-1): 
3112, 2927, 1621, 1608, 1530, 1348, 1322, 1162, 1116, 1091, 1066, 1017, 982, 909, 849, 
756, 713, 696, 630.  HRMS (ESI): Calcd. for C15H12N2O4 F3S ([M+H]+) m/z 373.04644, 
Found 373.04658.  HPLC: Whelk-01 (98 hexanes:02 isopropanol @ 1.0 ml/min): 76%ee;  
43 min (minor) and 51 min (major). 
N
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NO2  
2-(Naphthalen-2-yl)-1-(4-nitrophenylsulfonyl)aziridine (65ej) was obtained using the 
general procedure as tan solid in 75% yield (53.5 mg). [α]20D = -232 (c = 0.40, CHCl3). 
1H NMR (400 MHz, CDC13): δ 8.38 (d, J = 8.4 Hz, 2H), 8.21 (d, J = 8.8 Hz, 2H), 7.81 
(m, 3H), 7.74 (s, 1H), 7.50 (m, 2H), 7.27 (m, 1H), 4.07 (m, 1H), 3.20 (d, J = 7.2 Hz, 1H), 
2.63 (d, J = 4.4 Hz, 1H).  13C NMR (125 MHz, CDC13): δ 150.6, 143.9, 133.2, 132.9, 
131.4, 129.1, 128.7, 127.75, 127.73, 126.6, 126.5, 126.2, 124.3, 123.2, 42.2, 36.6.  IR 
(neat, cm-1): 3107, 2922, 1604, 1529, 1401, 1346, 1326, 1305, 1156, 1092, 949, 917, 862, 
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852, 800, 767, 742, 713, 679, 669, 640, 623, 608.  HRMS (ESI): Calcd. for C18H15N2O4S 
([M+H]+) m/z 355.07470, Found 355.07456. 
N
S
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N-(4-(2-p-Tolylaziridin-1-ylsulfonyl)phenyl)acetamide (65cb)  was obtained using the 
general procedure as tan oil in 83% yield (55.1 mg).  1H NMR (400 MHz, CDC13): δ 
7.98 (s, 1H), 7.86 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.08 (s, 4H), 3.71 (dd, J = 
6.8, 4.4 Hz, 1H), 2.93 (d, J = 6.8 Hz, 1H), 2.39 (d, J = 4.4 Hz, 1H), 2.29 (s, 3H), 2.16 (s, 
3H). 13C NMR (100 MHz, CDC13): δ 168.9, 148.9, 138.3, 132.0, 131.6, 129.2, 129.1, 
126.3, 119.2, 41.2, 35.8, 24.6, 21.2.  IR (neat, cm-1): 3346, 3111, 1701, 1590, 1529, 1402, 
1370, 1320, 1261, 1155, 1093, 909, 820, 731, 683, 635, 619.  HRMS (APCI): Calcd. for 
C17H19N2O3S ([M+H]+) m/z 331.11109, Found 331.11052. 
N
S
O
O
N
H
O
 
N-(4-(2-(4-tert-Butylphenyl)aziridin-1-ylsulfonyl)phenyl)acetamide (65ce)  was 
obtained using the general procedure as tan oil in 84% yield (62.3 mg).  1H NMR (400 
MHz, CDC13): δ 8.00 (s, 1H), 7.87 (d, J = 8.8 Hz, 2H), 7.68 (d, J = 8.8 Hz, 2H), 7.31 (d, 
J = 8.0 Hz, 2H), 7.12 (d, J = 8.4 Hz, 2H), 3.74 (dd, J = 7.2, 4.8 Hz, 1H), 2.94 (d, J = 7.2 
Hz, 1H), 2.39 (d, J = 4.8 Hz, 1H), 2.17 (s, 3H), 1.27 (s, 9H). 13C NMR (100 MHz, 
CDC13): δ 169.0, 151.5, 143.0, 132.0, 131.6, 129.1, 126.2, 125.5, 119.2, 41.1, 35.9, 34.5, 
31.2, 24.5.  IR (neat, cm-1): 3334, 2965, 1703, 1591, 1529, 1402, 1365, 1321, 1263, 1156, 
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1093, 910, 839, 749, 731, 689, 639, 617.  HRMS (APCI): Calcd. for C20H25N2O3S 
([M+H]+) m/z 373.15804, Found 373.15904. 
N
S
O
O
N
H
O
Cl
 
N-(4-(2-(4-Chlorophenyl)aziridin-1-ylsulfonyl)phenyl)acetamide (65cf)  was obtained 
using the general procedure as tan oil in 93% yield (65.3 mg).  1H NMR (400 MHz, 
CDC13): δ 7.98 (s, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.22 (d, J = 8.4 
Hz, 2H), 7.10 (d, J = 8.4 Hz, 2H), 3.68 (dd, J = 7.2, 4.4 Hz, 1H), 2.93 (d, J = 7.2 Hz, 1H), 
2.33 (d, J = 4.4 Hz, 1H), 2.16 (s, 3H). 13C NMR (100 MHz, CDC13): δ 168.9, 143.1, 
134.2, 133.3, 131.8, 129.1, 128.7, 127.8, 119.2, 40.3, 36.1, 24.7.  IR (neat, cm-1): 3333, 
3112, 1701, 1590, 1529, 1494, 1402, 1370, 1322, 1262, 1156, 1092, 1014, 981, 908, 827, 
776, 735, 689, 637, 623, 613.  HRMS (APCI): Calcd. for C16H16N2O3SCl ([M+H]+) m/z 
351.05647, Found 351.05748. 
6.5. Supporting Information for Chapter 5 
An oven dried Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, was charged with azide (if solid, 0.2 mmol), catalyst (0.004 mmol), and 5Å 
MS (100 mg).  The Schlenk tube was then evacuated and back filled with nitrogen.  The 
Teflon screw cap was replaced with a rubber septum and 0.5 ml of solvent was added 
followed by azide (if liquid, 0.2 mmol) and the remaining solvent (total 1mL).  The 
Schlenk tube was then purged with nitrogen for 2 minutes and the rubber septum was 
replaced with a Teflon screw cap.  The Schlenk tube was then placed in an oil bath for the 
desired time and temperature.  Following completion of the reaction, the reaction mixture 
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was concentrated and purified by dry loading the sample on a Teledyne flash 
chromatography instrument running a gradient solvent system of 100:0 (hexanes: ethyl 
acetate) to 50:50 (hexanes: ethyl acetate).  The fractions containing product were 
collected and concentrated by rotary evaporation to afford the pure compound. 
SO
O
NH
 
70a was synthesized by the general procedure from 2,4,6-triisopropylbenzene-1-sulfonyl 
azide as a tan solid in 96% yield (54.2mg). 1H NMR (400 MHz, CDC13): δ 7.21 (s, 1H), 
6.98 (s, 1H), 4.68 (s, 1H), 3.60 (heptet, J = 6.8 Hz, 1H), 2.97 (heptet, J = 6.8 Hz, 1H), 
1.62 (s, 6H), 1.34 (d, J = 6.8 Hz, 6H), 1.26 (d, J = 6.8 Hz, 6H). 13C NMR (100 MHz, 
CDC13): δ 155.4, 146.7, 145.2, 130.8, 124.2, 117.7, 59.72, 34.58, 29.81, 29.38, 23.81, 
23.51. IR (neat, cm–1): 3244, 2960, 2922, 2865, 1598, 1459, 1382, 1295, 1172, 1151, 
1129. HRMS (ESI): Calcd. for C15H23NO2SNa ([M+Na]+) m/z 304.13417, Found 
304.13441. 
SO
O
NH
 
70b was synthesized by the general procedure from 2,5-diisopropylbenzene-1-sulfonyl 
azide as a tan solid in 94% yield (45.0mg).  1H NMR (400 MHz, CDC13): δ 7.57(s, 1H), 
7.47 (dd, J = 8.0,1.2 Hz, 1H), 7.28 (d, J = 8.0Hz, 1H),  4.61 (s, 1H), 3.00 (heptet, J = 7.2 
Hz, 1H), 1.63 (s, 6H), 1.27 (d, J = 7.2 Hz, 6H). 13C NMR (100 MHz, CDC13): δ 150.5, 
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143.5, 135.1, 132.1, 122.5, 118.4, 60.62, 33.95, 29.68, 23.71. IR (neat, cm–1): 3240, 2965, 
2930, 2899, 2871, 1486, 1463, 1382, 1302, 1277, 1158, 1143, 1122, 1073. HRMS (ESI): 
Calcd. for C12H18NO2S ([M+H]+) m/z 240.10528, Found 240.10532. 
SO
O
NH
 
70c was synthesized by the general procedure from 2,4,6-triethylbenzene-1-sulfonyl 
azide as a tan oil in 90% yield (43.2mg).  1H NMR (400 MHz, CDC13): δ 7.11 (s, 1H), 
6.96 (s, 1H), 4.68 (m, 1H), 4.64 (m, 1H), 2.98 (q, J = 7.6 Hz, 2H), 2.70 (q, J = 7.6 Hz, 
2H), 1.57 (d, J = 6.8 Hz, 3H), 1.33 (t, J = 7.6 Hz, 3H), 1.25 (t, J = 7.6 Hz, 3H). 13C NMR 
(100 MHz, CDC13): δ 150.6, 142.4, 140.1, 131.3, 128.6, 120.2, 52.64, 28.99, 24.62, 
21.55, 15.36, 14.57.  IR (neat, cm–1): 3251, 2976, 2935, 2875, 1600, 1459, 1374, 1279, 
1174, 1146. HRMS (ESI): Calcd. for C12H18NO2S ([M+H]+) m/z 240.10528, Found 
240.10416. 
SO
O
NH
 
70d was synthesized by the general procedure from 2,5-diethylbenzene-1-sulfonyl azide 
as a tan oil in 91% yield (38.6mg).  1H NMR (400 MHz, CDC13): δ 7.57 (s, 1H), 7.44 (d, 
J = 8.0 Hz, 1H), 7.27 (d, J = 8.0 Hz, 1H), 4.81 (s, 1H), 4.78-4.70 (m, 1H), 2.74 (q, J = 7.6 
Hz, 2H), 1.58 (d, J = 6.8 Hz, 3H), 1.26 (t, J = 7.6 Hz, 3H).  13C NMR (100 MHz, 
CDC13): δ 146.2, 139.3, 135.7, 133.5, 123.8, 120.1, 53.40, 28.77, 21.75, 15.46.  IR (neat, 
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cm–1): 3256, 2932, 1489, 1455, 1417, 1372, 1282, 1211, 1150. HRMS (ESI): Calcd. for 
C10H14NO2S ([M+H]+) m/z 212.07398, Found 212.07422. 
SO
O
NH
 
70e was synthesized by the general procedure from 2,4,6-trimethylbenzene-1-sulfonyl 
azide as a tan solid in 96% yield (38.1mg).  1H NMR (400 MHz, CDC13): δ 7.04 (s, 1H), 
6.94 (s, 1H), 4.87 (s, 1H), 4.42 (d,  J = 5.2 Hz, 2H), 2.56 (s, 3H), 2.38 (s, 3H).  13C NMR 
(100 MHz, CDC13): δ 144.0, 137.2, 133.9, 131.5, 131.3, 122.2, 45.06, 21.44, 16.78.  IR 
(neat, cm–1): 3236, 2957, 2920, 1594, 1447, 1379, 1281, 1170, 1146. HRMS (ESI): 
Calcd. for C9H12NO2S ([M+H]+) m/z 198.05833, Found 198.05891. 
SO
O
NH
 
70f was synthesized by the general procedure from 2,3,5,6-tetramethylbenzene-1-
sulfonyl azide as a tan solid in 91% yield (38.5mg). 1H NMR (400 MHz, CDC13): δ 7.15 
(s, 1H), 4.79 (s, 1H), 4.32 (d, J = 5.2 Hz, 2H), 2.49 (s, 3H), 2.29 (s, 3H), 2.19 (s, 3H).  
13C NMR (125 MHz, DMSO): δ 140.0, 136.1, 133.1, 132.1, 129.6, 127.5, 43.40, 16.16, 
15.34, 14.37, 14.27.  IR (neat, cm–1): 3269, 2959, 2929, 2858, 1727, 1490, 1460, 1382, 
1268, 1138, 1072, 1038. HRMS (ESI): Calcd. for C10H14NO2S ([M+H]+) m/z 212.07398, 
Found 212.07460. 
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SO
O
NH
 
70g was synthesized by the general procedure from 2,3,4,5,6-pentamethylbenzene-1-
sulfonyl azide as a tan solid in 95% yield (42.6mg). 1H NMR (400 MHz, CDC13): δ 4.89 
(s, 1H), 4.33 (d, J = 5.2 Hz, 2H), 2.53 (s, 3H), 2.25 (s, 3H), 2.36 (s, 3H), 2.12 (s, 3H).  
13C NMR (125 MHz, DMSO): δ 137.5, 134.8, 134.5, 133.6, 131.2, 127.9, 42.81, 18.38, 
16.35, 13.13.  IR (neat, cm–1): 3250, 2957, 2929, 2871, 1728, 1458, 1378, 1272, 1200, 
1148, 1072, 1036. HRMS (ESI): Calcd. for C11H16NO2S ([M+H]+) m/z 226.08963, 
Found 226.08941. 
SO
O
NH
Br
 
70h was synthesized by the general procedure from 4-bromo-2-ethylbenzene-1-sulfonyl 
azide as a tan solid in 93% yield (48.9mg). 1H NMR (400 MHz, CDC13): δ 7.65-7.59 (m, 
2H), 7.53 (s, 1H), 4.96 (s, 1H), 4.78-4.71 (m, 1H), 1.60 (d, J = 6.8 Hz, 3H). 13C NMR 
(100 MHz, CDC13): δ 143.8, 134.6, 132.5, 127.8, 127.2, 122.5, 52.91, 21.15.  IR (neat, 
cm–1): 3268, 2966, 2924, 2871, 1727, 1572, 1459, 1389, 1320, 1284, 1193, 1165, 1138, 
1073. HRMS (ESI): Calcd. for C8H12N2O2SBr ([M+NH4]+) m/z 278.97974, Found 
278.97988. 
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SO
O
NH
O2N
 
70i was synthesized by the general procedure from 2-ethyl-5-nitrobenzene-1-sulfonyl 
azide as a tan solid in 99% yield (45.2mg).  1H NMR (400 MHz, CDC13): δ 8.60 (d, J = 
1.6 Hz, 1H), 8.49 (dd, J = 8.4, 2.0 Hz, 1H), 7.60 (d, J = 8.4 Hz, 1H) 4.91 (s, 1H), 4.87 (m, 
1H), 1.69 (d, J = 6.4 Hz, 3H).  13C NMR (100 MHz, CDC13): δ 148.5, 147.7, 137.5, 
128.1, 125.3, 117.4, 53.32, 21.40.  IR (neat, cm–1): 3243, 1600, 1529, 1351, 1282, 1162, 
1137, 1094, 1049, 1025.  HRMS (ESI): Calcd. for C8H12N3O4S ([M+NH4]+) m/z 
246.05430, Found 246.05436. 
SO
O
NH
 
70j was synthesized by the general procedure from 2,5-dicyclohexylbenzene-1-sulfonyl 
azide as a tan solid in 87% yield (55.4mg).  1H NMR (400 MHz, CDC13): δ 7.53 (s, 1H), 
7.42 (dd, J = 8.0, 1.2 Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 4.67 (s, 1H), 2.59-2.46 (m, 1H), 
1.85-1.73 (m, 12H), 1.63-1.53 (m, 2H), 1.44-1.21 (m, 6H).  13C NMR (100 MHz, 
CDC13): δ 149.8, 143.6, 135.3, 132.3, 122.7, 118.9, 63.47, 44.24, 37.75, 34.21, 26.63, 
25.89, 24.78, 22.55.  IR (neat, cm–1): 3268, 2928, 2851, 1728, 1447, 1384, 1296, 1268, 
1164, 1137, 1072.  HRMS (ESI): Calcd. for C18H26NO2S ([M+H]+) m/z 320.16788, 
Found 320.16886. 
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SO
O
NH
C4H9
 
70k was synthesized by the general procedure from 2,5-dibutylbenzene-1-sulfonyl azide 
as a tan oil.  Extensive efforts were made to attempt the separation of the 5-membered 
from 6-membered ring products. However, we were only able to isolate a small fraction 
of the pure 5-membered ring products in both of the cases, which allowed for NMR 
assignments and determination of the 5- to 6-membered ring product ratios by integration 
from 1H NMR spectra of 5- and 6-membered ring product mixtures.  1H NMR (400 MHz, 
CDC13): δ 7.56 (s, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 7.6 Hz, 1H) 4.66-4.60 (m, 
2H), 2.70 (t, J = 7.6 Hz, 2H), 1.95-1.90 (m, 1H), 1.77-1.70 (m, 1H), 1.62 (m, 2H), 1.52-
1.44 (m, 2H), 1.36 (sext, J = 7.2 Hz, 2H), 0.98 (t, J = 7.2 Hz, 3H), 0.95 (t, J = 7.2 Hz, 
3H).  13C NMR (125 MHz, CDC13): δ 144.8, 137.9, 135.5, 133.6, 123.7, 120.5, 57.51, 
37.69, 35.23, 33.23, 22.19, 13.82, 13.71.  IR (neat, cm–1): 3259, 2958, 2931, 2872, 1489, 
1465, 1381, 1287, 1152, 1107.  HRMS (ESI): Calcd. for C14H22NO2S ([M+H]+) m/z 
268.13658, Found 268.13665. 
SO
O
NH
C3H7
 
70l was synthesized by the general procedure from 2,5-dipropylbenzene-1-sulfonyl azide  
as a tan oil.  Extensive efforts were made to attempt the separation of the 5-membered 
from 6-membered ring products. However, we were only able to isolate a small fraction 
of the pure 5-membered ring products in both of the cases, which allowed for NMR 
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assignments and determination of the 5- to 6-membered ring product ratios by integration 
from 1H NMR spectra of 5- and 6-membered ring product mixtures.  1H NMR (400 MHz, 
CDC13): δ 7.57 (s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.4 Hz, 1H), 4.62 (m, 2H), 
2.68 (t, J = 7.6 Hz, 2H), 2.05-2.00 (m, 1H), 1.83-1.78 (m, 1H), 1.67 (sext, J = 7.6 Hz, 
2H), 1.03 (t, J = 7.2 Hz, 3H), 0.95 (t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDC13): δ 
144.6, 137.5, 135.7, 133.6, 123.7, 120.6, 58.85, 37.56, 28.72, 24.22, 13.66, 9.88.  IR 
(neat, cm–1): 3272, 2964, 2931, 2872, 1489, 1458, 1379, 1281, 1151, 1094, 1049.  HRMS 
(ESI): Calcd. for C12H18NO2S ([M+H]+) m/z 240.10528, Found 240.10521. 
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Chapter 7 
Spectral Data 
6.1. Spectral Data for Chapter 2 
Spectra 6.1.1. 1H and 13C NMR for 10a.   
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Spectra 6.1.2. GC/MS Spectra for 10a.   
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Spectra 6.1.3. 1H and 13C NMR for 10b.   
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Spectra 6.1.4. GC/MS Spectra for 10b.   
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Spectra 6.1.5. 1H and 13C NMR for 10c.   
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Spectra 6.1.6. GC/MS Spectra for 10c. 
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Spectra 6.1.7. 1H and 13C NMR for 10d.   
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Spectra 6.1.8. GC/MS Spectra for 10d. 
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Spectra 6.1.9. 1H and 13C NMR for 10e.   
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 120
Spectra 6.1.10. GC/MS Spectra for 10e. 
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Spectra 6.1.11. 1H and 13C NMR for 10f. 
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Spectra 6.1.12. GC/MS Spectra for 10f. 
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Spectra 6.1.13. 1H and 13C NMR for 10g. 
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Spectra 6.1.14. GC/MS Spectra for 10g. 
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Spectra 6.1.15. 1H and 13C NMR for 10h.  
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Spectra 6.1.16. GC/MS Spectra for 10h. 
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Spectra 6.1.17. 1H and 13C NMR for 10i.  
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Spectra 6.1.18. GC/MS Spectra for 10i. 
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6.2. Spectral Data for Chapter 3 
Spectra 6.2.1. 1H and 13C NMR for 56a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 130
Spectra 6.2.2. HPLC Spectra for 56a. 
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Spectra 6.2.3. 1H and 13C NMR for 56b. 
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Spectra 6.2.4. HPLC Spectra for 56b. 
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Spectra 6.2.5. 1H and 13C NMR for 56c. 
 
 
N
O
O
O
O
t-Bu  
 
 
 
 
 
 
 
 
 
                                                       
N
O
O
O
O
t-Bu  
 
 
 
 
 
 134
Spectra 6.2.6. HPLC Spectra for 56c. 
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Spectra 6.2.7. 1H and 13C NMR for 56d. 
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Spectra 6.2.8. HPLC Spectra for 56d. 
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Spectra 6.2.9. 1H and 13C NMR for 56e. 
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Spectra 6.2.10. HPLC Spectra for 56e. 
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Spectra 6.2.11. 1H and 13C NMR for 56f. 
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 140
Spectra 6.2.12. HPLC Spectra for 56f. 
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Spectra 6.2.13. 1H and 13C NMR for 56g. 
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Spectra 6.2.14. HPLC Spectra for 56g. 
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Spectra 6.2.15. 1H and 13C NMR for 56h. 
 
 
 
 
 
 
 
 
 
 
 
N
O
O
O
OO2N
 
 
 
 
 
 
 
 144
Spectra 6.2.16. HPLC Spectra for 56h. 
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Spectra 6.2.17. 1H and 13C NMR for 56i. 
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Spectra 6.2.18. HPLC Spectra for 56i. 
 
 
 147
Spectra 6.2.19. 1H and 13C NMR for 56j. 
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Spectra 6.2.20. HPLC Spectra for 56j. 
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Spectra 6.2.21. 1H and 13C NMR for 56k. 
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Spectra 6.2.22. HPLC Spectra for 56k. 
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Spectra 6.2.23. 1H and 13C NMR for 56l. 
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Spectra 6.2.24. HPLC Spectra for 56l. 
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Spectra 6.2.25. 1H and 13C NMR for 57a. 
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Spectra 6.2.26. HPLC Spectra for 57a. 
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Spectra 6.2.27. 1H and 13C NMR for 57b. 
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Spectra 6.2.28. HPLC Spectra for 57b. 
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Spectra 6.2.29. 1H and 13C NMR for 57c. 
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Spectra 6.2.30. HPLC Spectra for 57c. 
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Spectra 6.2.31. 1H and 13C NMR for 57d. 
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Spectra 6.2.32. HPLC Spectra for 57d. 
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Spectra 6.2.33. 1H and 13C NMR for 57e. 
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Spectra 6.2.34. HPLC Spectra for 57e. 
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Spectra 6.2.35. 1H and 13C NMR for 57f. 
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Spectra 6.2.36. 1H and 13C NMR for 57g. 
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Spectra 6.2.37. 1H and 13C NMR for 57h. 
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Spectra 6.2.38. 1H and 13C NMR for 57i. 
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Spectra 6.2.39. 1H and 13C NMR for 57j. 
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6.3. Spectral Data for Chapter 4 
Spectra 6.3.1. 1H NMR for P7. 
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Spectra 6.3.2. 1H and 13C NMR for 65aa. 
 
 
 
 
 
 
 
 
 
 
 
 
                                  
 
 
 
 
 
 
 170
Spectra 6.3.3. HPLC Specta for 65aa. 
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Spectra 6.3.4. 1H and 13C NMR for 65ba. 
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Spectra 6.3.5. HPLC Spectra for 65ba. 
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Spectra 6.3.6. 1H and 13C NMR for 65ca. 
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Spectra 6.3.7. 1H and 13C NMR for 65da. 
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Spectra 6.3.8. HPLC Spectra for 65da. 
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Spectra 6.3.9. 1H and 13C NMR for 65ea. 
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Spectra 6.3.10. HPLC Spectra for 65ea. 
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Spectra 6.3.11. 1H and 13C NMR for 65fa. 
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Spectra 6.3.12. HPLC Spectra for 65fa. 
 
 
 180
Spectra 6.3.13. 1H and 13C NMR for 65ga. 
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Spectra 6.3.14. 1H and 13C NMR for 65eb. 
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Spectra 6.3.15. HPLC Spectra for 65eb. 
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Spectra 6.3.16. 1H and 13C NMR for 65ec. 
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Spectra 6.3.17. HPLC Spectra for 65ec. 
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Spectra 6.3.18. 1H and 13C NMR for 65ed. 
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Spectra 6.3.19. HPLC Spectra for 65ed. 
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Spectra 6.3.20. 1H and 13C NMR for 65ee. 
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Spectra 6.3.21. HPLC Spectra for 65ee. 
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Spectra 6.3.22. 1H and 13C NMR for 65ef. 
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Spectra 6.3.23. HPLC Spectra for 65ef. 
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Spectra 6.3.24. 1H and 13C NMR for 65eg. 
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Spectra 6.3.25. HPLC Spectra for 65eg. 
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Spectra 6.3.26. 1H and 13C NMR for 65eh. 
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Spectra 6.3.27. HPLC Spectra for 65eh. 
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Spectra 6.3.28. 1H and 13C NMR for 65ei. 
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Spectra 6.3.29. HPLC Spectra for 65ei. 
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Spectra 6.3.30. 1H and 13C NMR for 65ej. 
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Spectra 6.3.31. 1H and 13C NMR for 65cb. 
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Spectra 6.3.32. 1H and 13C NMR for 65ce. 
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Spectra 6.3.33. 1H and 13C NMR for 65cf. 
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6.4. Spectral Data for Chapter 5 
Spectra 6.4.1. 1H and 13C NMR for 70a. 
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Spectra 6.4.2. 1H and 13C NMR for 70b. 
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Spectra 6.4.3. 1H and 13C NMR for 70c. 
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Spectra 6.4.4.  1H and 13C NMR for 70d. 
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Spectra 6.4.5.  1H and 13C NMR for 70e. 
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Spectra 6.4.6. 1H and 13C NMR for 70f. 
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Spectra 6.4.7. 1H and 13C NMR for 70g. 
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Spectra 6.4.8. 1H and 13C NMR for 70h. 
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Spectra 6.4.9. 1H and 13C NMR for 70i. 
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Spectra 6.4.10. 1H and 13C NMR for 70j. 
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Spectra 6.4.11. 1H NMR for 70ka + 70kb. 
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Spectra 6.4.12. 1H and 13C NMR for 70ka. 
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Spectra 6.4.13. 1H NMR for 70la + 70lb. 
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Spectra 6.4.14. 1H and 13C NMR for 70a. 
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